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Abstract 
An occult pneumothorax is defined as air within the pleural cavity diagnosed with a 
computed tomography (CT) scan which has not been suspected on the basis of 
clinical findings or chest X-ray.  The best management strategy has remained 
unclear, with inconsistencies in the guidelines, literature and speciality opinion.  As 
a high percentage of trauma patients require mechanical ventilation either for 
general anaesthesia or intensive care stay due to the nature of their injuries, the 
question of how to manage occult pneumothoraces in this population continues to be 
raised.  The aim of the research presented in this thesis was to investigate the safety 
and effectiveness of conservative management versus intercostal catheter (ICC) 
insertion for the management of occult pneumothoraces in mechanically ventilated 
patients. JBI systematic review methodology and methods were employed to address 
this aim. 
 
A search for published and unpublished literature included PubMed, Embase, 
CINAHL, Web of Science, Cochrane Central Register of Controlled Trials, ICTR, 
ANZCTR and ClinicalTrials.gov.  Following the database search, hand searching of 
reference lists from included articles was conducted.  Studies were included if they 
explored the effectiveness of conservative management versus ICC insertion for the 
management of occult pneumothoraces in mechanically ventilated patients.  
Randomised controlled trials (RCTs) and cohort studies were included. Eligible 
studies were critically appraised by two reviewers using appropriate JBI tools to 
assess methodological quality.  Where required, contact was attempted with 
corresponding authors for clarifications and further data.  RCTs and cohort studies, 
where appropriate, were analysed in separate meta-analyses using mixed-methods 
logistic regression.  Sensitivity analyses were performed using Mantel-Haenszel and 
Peto models. 
 
The search yielded 2230 unique citations.  Following screening of titles and 
abstracts, 20 articles were retrieved for full-text screening.  Of these, one trial was 
ongoing and could not be included.  Two additional studies were identified through 
hand searching.  Twenty-one full-text articles were screened; eight were ineligible.  
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Two articles were from the same study, leaving 12 included studies (three RCTs and 
nine cohort studies) involving 311 participants (135 in RCTs and 176 in cohort 
studies).  One RCT had high methodological quality, while aspects of the remaining 
two trials were unclear.  Overall, the cohort studies fulfilled the majority of the 
quality appraisal criteria. 
 
For the primary outcomes, analysis of RCTs revealed with conservative 
management versus ICC insertion: progression of pneumothorax OR 2.36 (95% CI 
0.81-6.8, 3 RCTs), ICC insertion (any reason) OR 4.2 (95% CI 0.33-52.5, 2 RCTs). 
No result was statistically significant.  Similarly, considering the remaining 
outcomes, there were no statistically significant differences, except for ICC insertion 
(progression to simple pneumothorax); OR 4.8 (95% CI 1.01-23.6, 3 RCTs).  
Observational data confirmed these trends in the majority of outcomes; however, 
contradictory results were seen in the outcomes of pneumonia/empyema and ICC 
insertion (non-pneumothorax reasons).  Adverse events included tension 
pneumothorax and ICC complications.  Incidence of tension pneumothorax was 
2.5% in the conservative management group and 0.7% in the ICC group.  The 
incidence of ICC complications in the ICC group was 20% versus 3.8% of patients 
requiring an ICC with conservative management.  ICC complications were 
significantly lower in the conservative management group when an ICC was 
required in the RCTs (OR 0.12, 95% CI 0.01 – 2.26). 
 
In conclusion, conservative management and ICC insertion appeared equally 
effective for the management of occult pneumothorax in mechanically ventilated 
patients.  Conservative management can be seen as a safe alternative to ICC 
insertion, with a low percentage of failure of conservative management reported, a 
low tension pneumothorax rate and a lower ICC complication rate when an ICC is 
subsequently required.   
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Chapter 1: Introduction  
A previous ‘mini-review’ on the topic of conservative management of occult 
pneumothorax was published in 20101, including three randomised controlled trials 
(RCTs), with variable results for and against conservative management. A further 
review on blunt chest trauma in 20152 briefly mentioned management of occult 
pneumothorax.  This review included two RCTs and two retrospective cohort studies 
that showed no difference in conservative management and intercostal catheter 
(ICC) insertion for occult pneumothorax.2  However, there was no explanation as to 
why one RCT from the earlier review had not been included.  Neither of these 
reviews looked specifically at mechanically ventilated patients or provided a 
combined estimate of effect. Further published research exists on this topic.   
These reviews highlight the inconsistencies within the research of how best to 
manage occult pneumothoraces, and these inconsistencies are similarly apparent in 
clinical guidelines.  Workplace experience has further highlighted the lack of clear, 
consistent guidelines, with inconsistent practice seen in the management of occult 
traumatic pneumothoraces in mechanically ventilated patients and no clear rationale 
for the choice of management from one patient to another. This lack of consistent 
clinical practice can potentially lead to adverse outcomes for patients and potentially 
unnecessary interventions. 
The aim of the research presented in this thesis was to clarify the current available 
evidence so as to ideally and ultimately lead to clearer guidelines addressing the 
appropriate management of occult pneumothoraces, specifically, in mechanically 
ventilated patients. 
 
This first chapter of this thesis introduces important topics and issues to facilitate 
understanding of the research and results presented in this thesis.  This includes an 
introduction to basic lung anatomy, an introduction to pneumothorax (how it occurs, 
how it is diagnosed and managed, and its life-threatening sequalae, with emphasis 
on occult pneumothorax), an explanation of the techniques and complications of the 
common management strategy (ICC insertion), and an introduction to mechanical 
ventilation and how it affects lung physiology and the pathophysiology of 
pneumothoraces. 
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1.1 Lung anatomy   
The lungs are half-cone shaped organs that sit within the rib cage, separated by the 
mediastinum.  Anatomically, they include a base (positioned on the diaphragm), an 
apex (which projects above the first rib into the root of the neck) and two surfaces 
(see Figure 1.1). The costal surface lies adjacent to the ribs and chest wall, and the 
mediastinal surface lies against the mediastinum.  The right lung is made up of three 
lobes (superior, middle and inferior) and the left lung has two lobes (superior and 
inferior).3   
 
Figure 1.1: Anatomical features of the right lung 
Surrounding the lungs is the pleural cavity, a potential space containing a thin layer 
of serous fluid.  It is enclosed by the pleura, which is divided into the visceral pleura 
(which covers the lungs) and the parietal pleura (which covers the chest wall, 
diaphragm and mediastinum) (see Figure 1.2).  These two divisions attach at the 
hilum of the lung, at which blood vessels, bronchi and other structures enter the 
lung3 (see Figure 1.1).  The pressure in the pleural cavity is usually negative relative 
to atmospheric pressure due to the outward force of the rib cage and the tendency of 
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Figure 1.2: Pleural cavity  
 
1.2 Pneumothorax and occult pneumothorax 
A pneumothorax, commonly referred to as a ‘collapsed lung’, is the pathological 
presence of air within the pleural cavity.5,6  It occurs due to the development of a 
connection between the lung and pleural cavity, or between the atmosphere and 
pleural cavity through the chest wall.7  This connection allows air to move into the 
pleural cavity down a pressure gradient (see Section 1.2.1). 
An occult pneumothorax is defined as air within the pleural cavity that is diagnosed 
with a computed tomography (CT) scan but which has not been suspected on the 
basis of preceding clinical examination or chest X-ray.8-10  Occult pneumothorax 
was first described in the literature by Wall et al.11 in 1983 after the authors 
diagnosed pneumothoraces following abdominal CT scans that had not been 
diagnosed with preceding chest X-ray.  It was further described by Tocino et al.12 a 
year later, after pneumothoraces were identified at lung apices from CT scans of the 
head.  Extended focused assessment with sonography for trauma (eFAST) is 
commonly used in trauma, and as such ultrasound has been used as another method 
to diagnose occult pneumothoraces13, however, CT scan remains the gold 
standard.13,14  The overall incidence of occult pneumothorax in trauma patients is 
reported to be around 5%8,9, however not all trauma patients receive a CT scan so 





Pleural cavity  
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receive a CT scan; in this scenario the incidence of occult pneumothorax has been 
reported to be as high as 56%.15,16  CT scans have become more common place 
following traumatic injuries, with a study showing increased use of CT scans for 
blunt trauma over the period 1998-2004, increasing from 2.7% to 28.7%.17 This is 
likely due to CT scanners becoming increasingly more sensitive, with higher 
resolution and thinner slices.18,19  They have also become much faster and use less 
radiation18,19, which makes it a safer procedure for the patient.  Due to the increased 
utilisation of CT scans in trauma patients, more occult pneumothoraces will be 
diagnosed. 
 
1.2.1 Pathophysiology  
Pneumothorax occurs because the pressure in the pleural space is always less than 
both the alveolar and atmospheric pressure.  Therefore, if any connection occurs 
through the parietal or visceral pleura, air will flow into the pleural space until the 
pressure is equalised or the connection is closed.6,20   
Pneumothoraces have respiratory and cardiovascular effects, the full extent of which 
is not completely known.  There are a limited number of studies in this area, most of 
which have been on animal models.  The known effects to the respiratory system 
include decreased lung volumes and reduced PaO2 (arterial partial pressure of 
oxygen).6  Gilmartin et al.21 measured spirometry in six patients with 
pneumothoraces and showed that there was a decrease in vital capacity (VC), 
functional residual capacity (FRC) and total lung capacity (TLC), and that the 
pneumothorax produced a restrictive ventilatory defect.  These decreased lung 
volumes are often well tolerated in healthy individuals, especially in smaller 
pneumothoraces.  Results of a study by Kilburn22 using a dog model suggest this is 
likely due to compensatory mechanisms, including decreased dead space and an 
increase in the respiratory rate to maintain a normal minute volume.  Considering 
there are a few possible mechanisms for decreased PaO2, the answer is likely 
multifactorial.  However, the main suspected mechanism is anatomical shunts.  This 
is supported by a study on humans by Norris et al.23; the authors showed that after a 
pneumothorax has reduced lung volume by 25%, there is a near linear correlation 
between an increasing shunt (area of the lung which has blood flow but no 
ventilation) and decreased lung volume.  The authors also suggested that the 
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increased A-a gradient (difference between the alveolar and arterial partial pressure 
of oxygen) could be completely explained by the shunt.23  Shunts causing the 
decreased oxygenation is supported by Moran et al.24 who showed, again on a dog 
model, that the relative blood flow of the ipsilateral lung to the pneumothorax was 
not altered, however there was a reduction in ventilation, due to the closure of small 
airways as the lung volume decreased.25  This led to a decreased 
ventilation/perfusion (V/Q) ratio in the ipsilateral lung.  
A small to moderate pneumothorax has limited effect on the cardiovascular system6; 
the effects of a larger pneumothorax will be described in the next section. 
 
1.2.2 Tension pneumothorax 
Tension pneumothorax is a life-threatening condition.  It is thought to occur due to 
the presence of a one-way valve phenomenon in the connection through the pleura.26 
Mechanical ventilation is thought to increase the risk of progression to tension 
pneumothorax due to positive pressure in the lung, promoting movement of air into 
the pleural cavity.6 Tension pneumothorax can be defined using intrapleural 
pressure, clinically or radiologically.  In terms of intrapleural pressure, tension 
pneumothorax occurs when intrapleural pressure exceeds atmospheric pressure 
throughout expiration and often during inspiration.6  Clinically, it can be defined as 
haemodynamic compromise with improvement following release of gas on insertion 
of an ICC, or a hiss of air on thoracic needle decompression.26  It can also be defined 
by features on a chest X-ray, which can include mediastinal shift, depression of 
ipsilateral diaphragm, and a pneumothorax occupying greater than 50% of the 
hemithorax volume.27  However, a tension pneumothorax should be treated prior to 
imaging of the chest, if suspected. 
The physiological effects of a tension pneumothorax depend on whether the patient 
is mechanically ventilated or spontaneously breathing unassisted26 and also on the 
mode of ventilation (i.e. pressure or volume control).28  Studies in spontaneously 
breathing animals have shown progressive hypoxaemia, with maintenance of cardiac 
output.29  In these studies, the progressive hypoxaemia was likely due to shunts, 
suggested by maintenance of minute volume and normocapnia, and cardiac output 
was maintained despite a decreased stroke volume through compensatory 
tachycardia.26  Decompensation occurs due to severe hypoxia causing sudden 
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cardiovascular collapse.  The proposed pathophysiology of tension pneumothorax in 
unassisted spontaneously breathing patients is lung collapse, leading to shunts and 
hypoxaemia.  The lack of cardiovascular effects in this group of patients is thought 
to be due to increased ability to mount a tachycardic response, incomplete 
transmission of pressure to mediastinum/major vessels and maintenance of venous 
return through a siphon effect from increased negative contralateral intrathoracic 
pressures.27 
Studies in ventilated animals and patients have shown that cardiovascular effects 
predominate.  Multiple studies28,30-32 in ventilated animals have shown a significant 
decrease in cardiac output and mean arterial pressure (MAP) as the pneumothorax 
increases in size.  This decrease in cardiac output and MAP will eventually lead to 
PEA (pulseless electrical activity) cardiac arrest27,28 (defined as a cardiac arrest 
where there is loss of cardiac output despite ongoing electrical activity of the heart).  
In these studies, this occurred with maintenance of oxygen saturation.  A case series 
in patients with tension pneumothoraces supported the decreased cardiac output and 
MAP, and revealed a mild decrease in oxygenation.33  The haemodynamic effects 
are consistent in the literature, however there are some inconsistencies in the effect 
on oxygenation.26  The suggested pathophysiology in ventilated patients is impaired 
compensatory mechanisms (i.e. tachycardia) due to sedation and increased airway 
pressure obstructing venous return and blood flow through the lung (via increased 
pulmonary vascular resistance).26,27   
An interesting study by Nelson et al.28 explored the differences in the 
cardiorespiratory response to tension pneumothorax in volume and pressure 
controlled ventilation on a pig model.  The authors found that in volume controlled 
ventilation (a ventilation mode where the tidal volume is set for each breath), as they 
increased the pleural pressure there was a decrease in the cardiac output and MAP.28  
There was also a slower rise in central venous pressure (CVP) and pulmonary artery 
diastolic pressure (PAD)/ pulmonary capillary wedge pressure (PCWP), and a sharp 
decline in cardiac output and MAP, when there was equalisation of CVP and 
PAD/PCWP.28  This rapid decline led to PEA cardiac arrest, which was reversible 
with decompression of the tension pneumothorax.  There was no desaturation during 
this time, as ventilation was maintained by increasing airway pressures.  In pressure 
controlled ventilation (a ventilation mode where the pressure applied to the lungs is 
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set for each breath), they found that there was a rapid decrease in tidal volume as the 
pleural pressure increased.  This led to a rapid decrease in oxygen saturation and 
eventual bradycardia, hypotension and asystolic cardiac arrest secondary to the 
hypoxaemia.28 
Due to the life-threatening nature of tension pneumothoraces, immediate recognition 
and treatment are important.  Recommended treatment is immediate needle 
decompression or finger thoracotomy, followed by insertion of an ICC.34,35 
 
1.2.3 Signs and symptoms  
Common symptoms of a pneumothorax include chest pain and dyspnoea (shortness 
of breath).  Chest pain is commonly described as ‘sharp’ in nature and localised to 
one side of the chest.6  The signs of a pneumothorax are dependent on its size, with a 
small pneumothorax often being asymptomatic. 
Signs include expansion of the chest on the affected side with decreased movement 
during the respiratory cycle, absent or reduced breath sounds, hyperresonance to 
percussion, loss of tactile fremitus (palpation of chest wall to detect changes in 
vibrations during speech) and subcutaneous emphysema (air within subcutaneous 
tissue that can be felt during palpation).6,36,37  Rare signs include shifting of the liver 
inferiorly with right sided pneumothorax6 and clicks which are synchronised with 
the cardiac cycle with left sided pneumothorax (Hamman’s sign).36 
Late signs, which may suggest progression to tension pneumothorax (see Section 
1.2.2), include tachycardia, hypotension, cyanosis and deviation of the trachea away 
from the side of the pneumothorax. 
 
1.2.4 Pneumothorax categories  
Pneumothoraces can be categorised as spontaneous, iatrogenic or traumatic, based 
on their cause.   
1.2.4.1 Spontaneous pneumothorax 
Spontaneous pneumothorax occurs without a clear cause.  It can be divided into 
primary and secondary.  Primary spontaneous pneumothoraces occur in otherwise 
healthy individuals, commonly in their early twenties.  The mechanism of this is not 
completely understood.6  Secondary spontaneous pneumothoraces occur in 
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individuals with previous lung disease, e.g. chronic obstructive pulmonary disease 
(COPD), connective tissue disorders, asthma, lung cancer and lung infections.36 
1.2.4.2 Iatrogenic pneumothorax 
Iatrogenic pneumothorax occurs due to a diagnostic or therapeutic intervention (i.e. 
lung biopsy, intercostal block, ICC insertion, central venous catheter insertion).  It 
can be inadvertent or intended.6,37  Iatrogenic pneumothorax can also occur via 
pulmonary barotrauma (see Section 1.5.3) in a patient who is mechanically 
ventilated.  This is more common when high volumes and pressures are used.38 
1.2.4.3 Traumatic pneumothorax 
Traumatic pneumothorax can be caused by penetrating or blunt trauma.  In blunt 
trauma, pneumothorax can occur via three mechanisms.  First, fractured or 
dislocated ribs can lacerate the pleura or lung parenchyma.  In the case of no rib 
fracture/dislocation, which is common, there are two suspected mechanisms: either 
increased alveolar pressure, which can occur during sudden chest compression, 
leading to rupture of alveoli; or, uncommonly, increased pressure during the phase 
where the glottis is closed in the level of the bifurcation of the trachea and/or where 
bronchi separate, leading to rupture in the larger airways.7,39 
The mechanism in penetrating trauma is simpler and more direct, with air allowed to 
enter the pleural space through the chest wall or from the lungs due to damage to the 
pleura.7,39 
 
1.2.5 Diagnosis  
Pneumothorax may be suspected following clinical examination based on 
observation of common signs and symptoms (see Section 1.2.3), however is 
confirmed (except in the case of a suspected tension pneumothorax, which requires 
urgent treatment) with one of the following imaging modalities. 
1.2.5.1 Chest X-ray  
Pneumothorax can be diagnosed with an erect chest X-ray in most cases: by a 
visceral pleural line seen without distal lung markings.40  The size of a 
pneumothorax can be misleading on chest X-rays, with a 2cm margin of gas 
peripheral to the lung corresponding to 30-50% collapse.7,40  Small pneumothoraces 
can be difficult to diagnose with chest X-rays of trauma patients, as imaging often 
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occurs with the patient in the supine position due to potential spinal injuries.  Supine 
chest X-rays are inaccurate for diagnosing pneumothoraces as they result in air 
spreading out over the anterior chest.7,41  The sensitivity of supine chest X-rays is 
12-24% and specificity is 89-100%.42 There are some subtle signs in a supine chest 
X-ray that can indicate the presence of a pneumothorax, but they are difficult to 
observe and confirm in the emergency setting due to small screens, bright lights and 
time pressure.  These can include subcutaneous emphysema (air within the 
subcutaneous tissue seen with chest X-rays which is almost always an indicator of 
pneumothorax), deep sulcus sign43 (deepening of lateral costophrenic angle, a 
common sign), hyperlucent hemithorax and depressed/inverted diaphragm (can be a 
sign of impending tension pneumothorax).40,44-46  Rarer signs include the double 
diaphragm sign45 (second distinct line overlying the diaphragm, may represent thin 
line of air above diaphragm), sharpened cardiac silhouette/black stripe sign44 (thin 
layer of air extending along mediastinal and cardiac margins) and a floating 
pericardial fat pad47 (elevation of cardiac fat pad).   
Due to the issues with supine chest X-rays in trauma, there is a concern that some of 
the pneumothoraces seen on CT scans may be missed on the initial chest X-ray.  
Two studies42,48 have retrospectively investigated whether these pneumothoraces, 
reported as occult, have been actually missed on preceding chest X-rays.  They 
found that less than 20% of the reported occult pneumothoraces were missed and 
these were found due to inferences from subtle signs such as deep sulcus sign and 
subcutaneous emphysema. 
1.2.5.2 Computed tomography scan 
CT scans are not used to diagnose spontaneous pneumothoraces, however, they may 
be used to determine an underlying cause.  In trauma situations, CT scans are often 
ordered based on the mechanism of accident and injury (e.g. high-speed motor 
vehicle accident, fall from height), without necessarily any overt signs of underlying 
injury due to the high risk of occult injuries.  CT scans are used to identify spinal 
injuries, intra-abdominal injuries and occult life-threatening injuries (such as aortic 
injuries).35,49  Occult pneumothoraces are often an incidental finding in these trauma 
CT scans.  Due to the ability of CT scans to accurately report sizing and location of 
a pneumothorax, they are the gold standard for diagnosing traumatic occult 
pneumothoraces.13,14 
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1.2.5.3 Ultrasound  
Lung ultrasound is a relatively new technique (introduced over the last 20-30 years), 
as it was initially thought that air-filled lungs are not conducive to ultrasound 
techniques.  This is due to air not being able to transmit ultrasound waves, which 
causes a large amount of artefact.50,51  A better understanding of these artefacts has 
led to the increased use of lung ultrasound in the diagnosis of a number of 
conditions, including pneumothorax.51,52  The first artefact to be used for the 
diagnosis of pneumothorax was lung sliding.50  Lung sliding is the to-and-fro 
movement (also described as twinkling movement) visible at the pleural line, 
synchronised with respiration.  It corresponds to the visceral pleura sliding in contact 
with the parietal pleura.14,53,54 
The absence of lung sliding is highly suggestive of a pneumothorax, with a 
specificity of 78-100%.50,52,55 However, there are a number of other conditions that 
can cause loss of lung sliding.  These include inflammatory conditions (i.e. acute 
respiratory distress syndrome [ARDS]), right main bronchus intubation/one lung 
ventilation, cardiac arrest, apnoea, lung fibrosis, chronic adherences and phrenic 
nerve palsy.53,56  Due to this, other artefacts have been used to help improve the 
accuracy of lung ultrasound for diagnosis of pneumothorax.  A-lines are horizontal 
repetitions of the pleural line that are caused by reverberation artefacts.  In a normal 
lung, these reverberations will continue for a short period, and in a pneumothorax 
they continue throughout the image.  It can be visualised better in M-mode (images 
one slice of ultrasound over time), with a seashore sign53 seen in normal lung and a 
barcode or stratosphere sign51 seen in a pneumothorax.  B-lines are vertical lines 
(comet-tail artefacts) that arise from the pleural line, visualisation of B-lines 
excludes a pneumothorax.14,57 A lung point is described as an ultrasound window 
obtained between two ribs, where lung sliding is seen in part of the view and not the 
other. This is due to the sliding lung intermittently coming into contact with the 
chest wall during inspiration.14 Visualisation of the lung point sign is 
pathognomonic for pneumothorax53 and can be useful in assessing the size and 
extent of pneumothorax.51  In a large pneumothorax, a lung point may not be seen54 
due to no part of the lung coming into contact with the anterior chest wall.  The 
overall sensitivity and specificity of lung ultrasound for pneumothorax vary slightly 
in the literature, ranging from 60% to 95% and from 90% to 100%, 
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respectively14,50,58,59, depending on the study.  These variations can likely be 
explained by differences in patient populations, differences in operator 
experience56,57 and the artefacts used. 
Ultrasound outperforms chest X-ray for diagnosis of pneumothorax, especially 
occult pneumothorax.13 It is not as sensitive or specific as CT scans, however it has 
the benefit of being a rapid, clinician performed, bedside test.60 
 
1.3 Management of occult traumatic pneumothorax 
Although occult pneumothorax was first identified over 30 years ago, there is no 
consensus on the best management strategy; this is especially the case with patients 
receiving mechanical ventilation.  There are no clear guidelines and there are 
inconsistencies in the literature and medical practice.  The two possible approaches 
are conservative management (or observation) and insertion of an ICC, both of 
which have their own advantages and disadvantages. 
Conservative management involves a combination of serial examination and serial 
imaging (mostly chest X-rays) to monitor pneumothorax progression.  These 
patients are managed in a highly monitored environment, with high medical and 
nursing staff to patient ratios.  During conservative management, resolution of the 
pneumothorax occurs due to reabsorption of air from the pleural space.  How 
quickly this occurs depends on the gradients of various gases between the pleura and 
the venous blood.4   
Management with an ICC removes air directly from the pleural space into a drain 
outside the body via the inserted catheter.  It is a faster method of removing the air, 
however it involves an invasive procedure and associated complications (see Section 
1.4). 
The main source of trauma education internationally is the Advanced Trauma Life 
Support (ATLS) course.  Until recently, it recommended that all patients with 
pneumothoraces undergoing general anaesthesia or mechanical ventilation require 
insertion of an ICC.61  The most recent manual update (edition 1035) is less 
descriptive, stating that ideally a patient with a known pneumothorax should not 
undergo general anaesthesia or receive mechanical ventilation without having an 
ICC.  However, in selected circumstances (i.e. subclinical/occult pneumothorax), the 
Page 24 of 146 
 
trauma team may decide to carefully observe the patient.  The guidelines highlight 
the risk of tension pneumothorax while receiving mechanical ventilation.  This is 
more in keeping with the guidance from the Emergency Trauma Management 
(ETM) course34 (a recently formed Australasian critical care focused course).  It 
states that the classical teaching is that an ICC should be inserted if mechanical 
ventilation is required, however in centres with experienced staff, small/occult 
pneumothoraces may be closely observed. 
Inconsistencies in medical practice are confirmed by a survey completed in the UK, 
showing disagreement between medical specialties that commonly manage this 
group of patients, with prophylactic placement of an ICC varying from 28% to 
100%.62  Inconsistencies are also prevalent in the results of studies investigating 
management of occult pneumothorax.  The first RCT on the topic, by Enderson et 
al.63 in 1993, reported development of tension pneumothorax in three out of 15 
patients, with a further five requiring ICC placement for pneumothorax progression.  
From this study, it was recommended that all patients with occult pneumothorax 
who require mechanical ventilation also receive a prophylactic ICC.  Studies 
completed in the last decade have reported one tension pneumothorax with no 
mortality for conservative management and have reported a ‘failure’ of conservative 
management (defined as requirement for ICC insertion) between 8-30%.10,64,65  
Despite this apparent high failure rate, the corollary is that at least 70% of patients 
had avoided an unnecessary procedure, with its high complication rate and 
associated pain.  There have also been some earlier reviews on this topic1,2 which 
have had a small number of trials included (three RCTs in the first, and two RCTs 
and two cohort studies in the second) and have suggested, with low certainty, that 
conservative management may be safe. 
Due to the theoretical increased risk of tension pneumothorax in patients receiving 
mechanical ventilation, prophylactic insertion of an ICC is common.  Unfortunately, 
ICC insertion is not without risks and is associated with a major complication rate of 
approximately 20%.66  These risks are discussed below (see Section 1.4.3).  
Placement of an ICC does not completely reduce the risk of tension pneumothorax, 
due to the risk of malpositioning67, and may actually delay the diagnosis of a tension 
pneumothorax due to the assumption that the pneumothorax has been effectively 
treated.   
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Due to the lack of consensus in the guidelines and literature, there is a risk of harm 
to patients due to clinical practice variations. 
 
1.4 Intercostal catheter 
Thoracic drainage has been reportedly in use since Hippocrates in approximately 
400BC68; it has had an interesting development trajectory since then to the modern 
ICC. This section discusses the different insertion techniques of an ICC, parts of the 
anatomy important for insertion, how drainage works, and the complications 
associated with ICC insertion. 
 
1.4.1 Insertion techniques  
There are two main insertion techniques for ICCs.  The first is the Seldinger 
technique, which uses a needle, wire and dilator. The other is a surgical technique, 
which most commonly uses blunt dissection into the thoracic cavity between two 
ribs.  A third, the trocar technique, is now rarely used due to the high complication 
rate associated with its use. 
1.4.1.1 Safe insertion site 
The British Thoracic Society (BTS) recommends a safe zone for insertion of an ICC, 
termed the ‘safe triangle’.69,70  This safe triangle is bordered by the lateral edge of 
the latissimus dorsi and the lateral border of pectoralis major, and is superior to the 
horizontal level of the fifth intercostal space.  The apex of the triangle is the axilla.  
Some advocate a ‘quadrangle of safety’, which has a superior border of the third 
intercostal space.71  A study from the UK reported that, of a sample of 50 junior 
doctors, only 22 doctors’ planned insertion sites fell within the safe triangle72, 
showing that this safe insertion site is not well understood. 
Most guidelines70,71,73 recommend inserting the drain just superiorly to the inferior 
rib in the chosen intercostal space due to the classic teaching that the neurovascular 
bundle sits in the subcostal groove, which is just at the inferior border of the rib.  
However, this may not be the case.  A cadaveric study by Wraight et al.74 found that 
there were considerable variations in the position of the neurovascular bundle and 
suggested a narrow ‘safe zone’, 50-70% down the chosen intercostal space. 
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1.4.1.2 Seldinger technique  
The Seldinger technique was first described in 1953 as a method for inserting a 
catheter into an artery for percutaneous angiography.75  It has since been modified to 
be used for a number of procedures within critical care, including a technique for 
small-bore chest drain insertion.  This technique is used for catheters 20 French or 
less and can include straight or flexible pigtail catheters.76 
The technique involves the following steps70,71,76,77: 
1. Infiltrate local anaesthetic in insertion site, then use local anaesthetic needle 
as ‘seeker’ needle to confirm correct insertion site. 
2. Insert larger needle until confirmed in pleural space (by aspirating air or 
pleural fluid). 
3. Insert guidewire through needle so at least half the wire is in pleural cavity.  
4. Remove needle, leaving guidewire in situ. 
5. Pass dilator over guidewire to create a tract. 
6. Remove dilator and pass catheter over guidewire.  
7. Remove guidewire.  
8. Secure catheter and connect to drain.  
This technique is less painful than surgical techniques78 and negates the need for a 
large incision. 
1.4.1.3 Surgical technique – blunt dissection  
Surgical techniques are used when larger chest drains (>20 French) are required and 
are often used in the immediate management of trauma patients for large 
pneumothoraces or haemothoraces.73,76 
The technique uses the following steps70,71,73,76,77,79: 
1. Infiltrate local anaesthetic widely over incision area.  
2. Make an approximately 2cm wide incision (large enough for introduction of 
finger into pleural space) aligned to chosen intercostal space. 
3. Use large clamp (artery forceps, Kelly clamp or Harrison-Cripps forceps) to 
bluntly spread pericostal layers, until parietal pleura is breached.  
4. Place finger in pleural space alongside clamp and explore tract with finger, 
ensuring lung falls away from pleura (‘finger sweep’).  Once finger is in 
pleural space, clamp can be removed.  
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5. Use clamp to help place catheter past finger into pleural space; once catheter 
is in pleural space, unclamp and advance tube using finger to direct tube in 
desired direction, ensuring most distal hole is in pleural space. 
6. Secure catheter (sutures and dressing), suture skin closed around catheter and 
connect to drain. 
1.4.1.4 Surgical technique – trocar  
The trocar technique uses a chest tube that is fitted with an internal sharp and rigid 
metal obturator, which is used to penetrate the subcutaneous tissues using a twisting 
motion.  The trocar is inserted until a ‘pop’ sound is heard on entrance into the 
pleural space.79  The BTS guidelines recommend that trocars should not be used.70 
This is due to the high complication rate when trocars are used80, including damage 
to essential intrathoracic structures and malpositioning.  This is further discussed 
below (see Section 1.4.3). 
 
1.4.2 Drainage  
Drainage of a pneumothorax can be done via a Heimlich valve81,82 (a type of one-
way valve) that connects to the end of the catheter, the benefit of which is better 
portability than larger drainage systems.  However, the most common and safest 
method is an underwater seal drain.  Modern underwater seal drains use a three-
compartment system.  The first is a collection chamber, which allows measurement 
of fluid drained from the lungs.  The second is the underwater seal, which acts as a 
one-way valve, letting air exit from the pleural space on exhalation and preventing 
air from entering the pleural cavity on inhalation.83  The third compartment allows 
for negative pressure to be applied to the pleural cavity in order to facilitate re-
expansion of the lung via the application of suction.84  These three compartments are 
combined into one container for easy use and movement. 
 
1.4.3 Intercostal catheter complications 
In the literature, the incidence of ICC complications is reported to be around 20-
35%.66,85-89  A recent study from Iran reported a complication rate higher than 60% 
for ICC insertion performed by surgical and medical residents.90  ICC complications 
are reduced when the trocar is not used.91-93  A South African study94, where 75% of 
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insertions used a trocar, reported 58 organ injuries in 53 patients (i.e. some patients 
had more than one organ injury from their ICC insertion).  ICC complications, even 
tube malpositioning, are clinically important as they increase intensive care unit 
(ICU) and hospital length of stay.95   
ICC complications can be subdivided in a number of ways and are reported 
inconsistently in the literature.88  In this thesis, they have been divided into the 
subcategories of insertional, infectious, mechanical, post removal and other. 
1.4.3.1 Insertion 
The most common complication of ICC insertion is catheter malpositioning.91  It 
occurs most commonly with urgent ICC insertion due to suboptimal positioning, 
with less experienced operators or with pre-existing pulmonary pathology. The types 
of malpositioning include chest wall placement (tip of catheter in subcutaneous 
tissue), intrafissural (tip of catheter in lung fissure), intraparenchymal (tip of catheter 
in lung tissue, more common in the presence of adhesion or pre-existing lung 
disease), mediastinal placement and abdominal placement.91  The catheter may also 
be malpositioned across the anterior mediastinum when using a trocar, which can 
cause a contralateral pneumothorax.96  Catheter malpositioning will lead to no or 
inadequate drainage and may not be appreciated until there is clinical deterioration, 
as it may be missed with a post insertion chest X-ray.  CT scans may be required to 
fully appreciate the malpositioning, especially with intraparenchymal or intrafissural 
placement.97,98   
Damage can occur to any structure within the abdominal and thoracic cavity, 
including organs, blood and lymph vessels, and nerves.  Organ injuries can occur 
both within the thoracic cavity (lung, heart and oesophagus) and outside the thoracic 
cavity (liver, spleen, stomach and diaphragm).  In the thoracic cavity, the lung is the 
most commonly injured organ.99  A laceration of the lung can occur during insertion; 
this is often more common when inserting an ICC for non-pneumothorax reasons 
and can lead to a bronchopleural/alveolar-pleural fistula (an ongoing leak of air into 
the pleural space), which may require surgical repair.100  Cardiac and oesophageal 
injuries are rare99, however perforation of the oesophagus and catastrophic 
penetrating injury to the heart have been reported.  Compression of critical cardiac 
or vascular structures can also lead to haemodynamic compromise.101 
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The liver and spleen are the more common abdominal organs injured with ICC 
insertion, due to their close proximity to the diaphragm, however this has become 
less common with the decreased use of trocars for insertion.  Gastric and bowel 
perforations are rare but have been reported.99,100  Damage to the diaphragm can also 
occur, including laceration, perforation and muscle dysfunction.100 
Damage to blood vessels leads to haemorrhage, which can be serious, and blood loss 
into the pleural cavity can occur.  The most common site of vascular injury is the 
intercostal arteries91,100 (see Section 1.4.1.1).  Other potential vascular injuries 
include injury to the pulmonary arteries and occlusion of the subclavian artery.   
Nerve injury is rare, however damage can occur to the phrenic nerve, vagus nerve 
and sympathetic trunk.  Phrenic nerve palsy and acute diaphragmatic paralysis can 
occur (most frequently in neonates) due to compression of the phrenic nerve in the 
mediastinum.100  Injury to the sympathetic trunk can occur when an ICC is inserted 
high into the apex of the pleura100, and may result in Horner’s syndrome (which 
consists of miosis, ptosis, anhidrosis and enophthalmos).  Thoracic duct damage can 
occur, causing a lymph fluid leak into the pleural space.  This is a rare complication 
that is evident through milky drainage fluid that, when analysed, will show high 
triglyceride levels.100 
Insertion of a catheter or insertional wire into the thoracic cavity can cause 
mechanical stimulation of the heart, pericardium or vagus nerve. This can cause 
cardiac dysrhythmias, including atrial fibrillation and severe bradycardias.91 
Even when the catheter is positioned correctly, there is potential for an insertional 
complication if the lung re-expands too quickly.  Re-expansion pulmonary oedema 
is a rare condition (incidence is around 1%102) that can occur on expansion of the 
lung during drainage of a pneumothorax or pleural effusion.  It affects the ipsilateral 
lung and appears to be due to increased endothelial permeability and loss of integrity 
of the alveolar capillaries.91  The clinical picture can vary from asymptomatic chest 
X-ray changes, to mild respiratory symptoms with pink frothy sputum and 
tachypnoea, to dramatic respiratory failure.  It often self-resolves over a few hours.  
The risk factors for its development include young age, large pneumothorax (greater 
than 30% of the hemithorax), pneumothorax for greater than three days and greater 
than three litres of pleural fluid drained.91,102 
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1.4.3.2 Infection 
As with any foreign material that is inserted into the body, there is a risk of infection 
with an ICC.  Infection at the insertion site is the most common and can occur both 
while ICC is in situ and post removal.  The incidence of insertion site infection has 
been reported to be 7.7%.91  It is diagnosed based on the presence of erythema and 
swelling of surrounding skin and is treated with intravenous (IV) antibiotics.  It 
often requires the removal of the ICC to eradicate infection.   
More serious infectious complications include empyema and necrotising chest wall 
infections.  An empyema is an infected collection of fluid/pus within the pleural 
cavity.  Its incidence is around 1-2%.66,103,104  Risk factors for developing an 
empyema include penetrating mechanism, prolonged ICC dwell time, lung 
contusion, retained haemothorax, need for laparotomy and prolonged ICU stay.  The 
most important of these appears to be retained haemothorax104,105, due to blood 
being a good medium for bacterial growth.  Empyema often requires a surgical 
thoracotomy for wash out, along with IV antibiotics.  Necrotising chest wall 
infections are very rare and most commonly occur in the setting of empyema 
drainage.  It is a rapidly progressive life-threatening infection of the subcutaneous 
tissue that requires urgent surgery for debridement of necrotic tissue and broad-
spectrum IV antibiotics.99,100 
1.4.3.3 Mechanical complications 
Mechanical complications are defined as those relating to the catheter itself and 
include dislodgement, occlusion and erosion into surrounding structures.  
Dislodgement and occlusion often require placement of a new ICC.  Catheter 
dislodgement is more common in pigtail catheters as they are often not secured as 
tightly as larger ICCs.106 Agitated patients may also self-remove ICCs.   
Catheter occlusion can occur via blockage or kinking.  Both are more common with 
small bore catheters.  Blockage is more common when draining an effusion or 
haemothorax.106  The rate of blockage can be decreased by intermittently flushing 
the catheter.106  Catheter occlusion can cause accumulation of pneumothorax or 
haemothorax, which can lead to clinical deterioration.   
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Erosion into thoracic structures is a very rare delayed complication.  Continued 
direct contact between catheter and structures, along with constant motion due to 
respiration or cardiac rhythm is the most likely mechanism behind this.99 
1.4.3.4 Complications post removal of intercostal catheter 
Recurrence of the underlying condition is the main concern after removing an ICC.  
Recurrent pneumothorax following catheter removal can occur due to removing 
ICCs before the lung has fully expanded, bronchopleural/alveolar-pleural fistula or 
entrainment of air during removal.91  Risk factors for recurrence or development of a 
pneumothorax after catheter removal include younger age, penetrating mechanism 
and thin chest wall.107  Recurrent haemothorax/pleural effusion occurs due to 
ongoing pathology (e.g. bleeding or increased pleural fluid production) or if the ICC 
cannot drain all the fluid (due to positioning or loculation of fluid).  Rare 
complications post removal of ICCs includes retained catheter fragment (which can 
occur if damage to the catheter occurs on insertion100) and herniation of lung out of 
previous ICC site (very rare, but case reports exist91). 
1.4.3.5 Other complications 
Recurrent pneumothorax during ICC dwelling can occur if there is not an adequate 
seal with an occlusive dressing over the ICC insertion site.  Pneumothorax re-
accumulation occurs via air being entrained into the pleural cavity via the ICC tract.  
Once the seal is returned, the pneumothorax can again drain through the ICC.99 
 
1.4.4 Removal of intercostal catheter  
The decision to remove an ICC depends on the indication(s) for its insertion. 
If inserted for a pneumothorax, it can be removed when there is no longer evidence 
of pneumothorax with chest X-ray and there is no longer air being drained with a 
functioning ICC. 
If the ICC is inserted to drain pleural fluid, the criteria for removal is not as clear.  It 
is reported to be safe when less than 200-500ml is drained in 24 hours, however 
300ml is the most commonly reported volume considered to be safe.108,109  Some 
guidelines suggest a weight based volume of 15% of the total body lymph drainage, 
which is around 3.6ml/kg over a 24-hour period.110  After a haemothorax, the 
removal threshold is often more conservative, with less than 200ml in 24 hours 
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considered to be safe.111  It is considered safe to remove an ICC while a patient is 
receiving  mechanical ventilation if they meet the criteria for removal.111 
1.4.4.1 Technique for removal 
The technique for ICC removal focuses on preventing air from being entrained into 
the pleural space.  It involves removing the drain with a swift and gentle motion 
while simultaneously pinching the skin around the insertion site. This is then 
followed by applying an occlusive dressing; occasionally sutures or steri-strips are 
used to assist closure of the wound.70,76  There has been debate about when in the 
respiratory cycle the catheter should be removed.  The two main schools of thought 
are end-expiration or end-inspiration, with the breath held.  A study that compared 
the two techniques in awake patients showed that there was no difference in post 
removal pneumothorax.112  Another RCT113 found a significant decrease in recurrent 
pneumothorax with end-expiration.  However, many believe that in awake patients, 
it is the Valsalva manoeuvre (breath holding) which is important, and thus the 
recommendations are for consistency in practice of end-expiration or end-inspiration 
but ensuring breath holding, where possible.110  This is different in unconscious 
mechanically ventilated patients, where ICC removal should occur at end-inspiration 
when the intrathoracic pressure is positive.114 
 
1.5 Mechanical ventilation  
Mechanical ventilation is a technique of using a device (ventilator) to support, 
partially or totally, the delivery of gas into the lungs.  It is used to maintain adequate 
levels of oxygen and carbon dioxide in the blood and to reduce respiratory 
effort.115,116  It can cover non-invasive ventilation (via a mask) and invasive 
ventilation (via an endotracheal tube or tracheostomy tube).  For the purposes of this 
research, invasive ventilation only will be considered. 
The indications for mechanical ventilation include respiratory failure (type one – 
hypoxia, and type two – hypercarbia), increased work of breathing, airway 
protection (e.g. decreased conscious state) to reduce the risk of aspiration, upper-
airway obstruction, to assist sedation and neuromuscular paralysis (e.g. in the 
intensive care unit or during surgery), and in settings where ventilation control is 
necessary (e.g. controlling carbon dioxide levels in brain injuries).117,118 
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1.5.1 Physiological differences from normal breathing  
Ventilation involves movement of the chest wall to produce a pressure gradient that 
will permit flow and movement of gas.  This can be accomplished in spontaneous 
breathing by the respiratory muscles or by mechanical ventilation (positive pressure 
ventilation).119  During spontaneous inspiration, negative intrathoracic, intrapleural 
and alveolar pressure is brought about by the contraction of respiratory muscles.  
The generation of negative pressure allows for gas to flow into the lungs.  This is 
followed by expiration, which is generally a passive process but is occasionally  
assisted by respiratory muscles.4,117,120  During positive pressure ventilation, 
inspiration occurs due to airway pressure being raised, leading to gas flowing down 
a pressure gradient into the lungs.  This leads to positive intrathoracic, intrapleural 
and alveolar pressure.  Expiration is again a passive process.4,120,121  In summary, 
spontaneous breathing uses negative intrathoracic pressure and mechanical 
ventilation forces air into the lungs, causing relative positive pressure in the lungs 
and chest. 
1.5.2 Changes in mechanical ventilation over time  
Over the last 20 to 30 years, there have been changes in standard ventilatory 
settings.  The main change is a decrease in the set tidal volume for all patients.  A 
study in 2000122 showed that mortality was lower in patients with ARDS (a severe 
inflammatory lung disorder) when lower tidal volumes (6ml/kg vs 12ml/kg) were 
used for ventilation. The findings of this study have been supported by a systematic 
review.123  The results of the study in 2000 led to a change in practice, with 
decreased set tidal volumes used in the management of ARDS.124,125   
Meta-analyses of the effect of decreased tidal volumes in mechanically ventilated 
patients without ARDS have shown decreased incidence of lung injury and lung 
infection when used in general anaesthesia126, and decreased incidence of lung 
injury and decreased mortality when used in the ICU.127  Due to this, it has become 
common practice in all mechanically ventilated patients to aim for a tidal volume of 
6-8ml/kg ideal body weight.128  Despite this being the aim, it is not always 
achievable due to overestimation of ideal body weight129, concerns about ventilator 
dyssynchrony, and concerns about hypoventilation (hypercapnia and respiratory 
acidosis).130 
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1.5.3 Complications 
There are a number of potential complications associated with mechanical 
ventilation; for the purposes of this review the focus will mainly be on respiratory 
complications.  Respiratory complications include ventilator associated pneumonia 
(VAP) and ventilator-associated lung injury (which includes barotrauma, 
volutrauma, atelectotrauma, biotrauma and oxygen toxicity131).  Ventilated patients 
have a higher risk of developing pneumonia due to reduced function of protective 
mechanisms (the lung’s immune defences, swallowing, airway protective reflexes) 
and multiple risk factors associated with illness severity and ICU stay.  The 
incidence of VAP is reported to be between 8% and 28%132, and is increased in 
patients with severe underlying lung disease, aspiration pneumonia or pre-existing 
COPD.38  
Ventilator-associated lung injury encompasses a group of complications which can 
be further subdivided.  Barotrauma is damage to the lungs caused by sustained high 
pressure, which can lead to alveolar rupture, with air entering the pleural space 
causing pneumothorax and pneumomediastinum (air in mediastinal space).4,133  
Volutrauma is damage caused to the lungs by over-distension, which can 
particularly occur when a portion of the lung is receiving the majority of the tidal 
volume due to collapse of other areas.  Volutrauma, like barotrauma, can also lead to 
pneumothorax and pneumomediastinum.  It can also manifest as pulmonary oedema 
due to increased alveolar membrane permeability.4,131,134  Atelectotrauma is 
associated with repeated recruitment and collapse of alveoli, leading to oedema and 
lung inflammation.  Biotrauma, thought to be associated with volutrauma and 
atelectotrauma, is due to a proinflammatory response to ventilation, leading to lung 
inflammation via activation of immunological and coagulation systems.4,131,135  A 
proinflammatory response leading to tissue damage and cell death can also occur in 
response to high levels of inspired oxygen, which is caused by oxygen free radicals 
and reactive oxygen species.136  The exact level at which this damage occurs is 
unknown and likely to be different for each patient.    
Although it has been shown that these complications can occur due to mechanical 
ventilation, they can also be due to the underlying lung pathology necessitating the 
need for mechanical ventilation.  Distinguishing the cause of the complication can 
be difficult and often the cause is left unknown. 
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Non-respiratory complications include decreased venous return, leading to decreased 
cardiac output, salt and water retention due to decreased renal blood flow, increased 
intracranial pressure, sleep disturbance, delirium and discomfort.117,134 
 
1.6 Significance of the review  
Currently, there is a lack of consensus between guidelines, literature and specialist 
opinion on how to manage mechanically ventilated patients with occult 
pneumothoraces.  Across the world, there is increasing utilisation of conservative 
management in some facilities, however there are still ongoing variations between 
hospitals and specialists regarding the correct management strategy. 
The aim of the research presented in this thesis was to conduct a systematic review 
to establish the effectiveness of conservative management and determine the 
incidence of complications in both conservative management and ICC insertion in 
mechanically ventilated patients with traumatic occult pneumothorax.  Combining 
all available data on this topic will allow clinicians to make more informed decisions 
on management and may allow for more concise recommendations in the guidelines 
and teaching resources.  
 
1.7 Review objective and question 
The review objective was to locate, critically appraise and synthesise the best 
available evidence on the effectiveness and safety of conservative management of 
traumatic occult pneumothoraces in mechanically ventilated patients. 
 
The specific review question was: 
 
In the mechanically ventilated patient, is conservative management safe and 
effective for the management of traumatic occult pneumothorax when compared to 
insertion of a prophylactic intercostal catheter? 
 
1.8 Methodology overview 
A systematic review is a comprehensive summary of all available evidence relevant 
to a specific question.137  Systematic reviews are regarded as the highest level of 
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evidence and therefore often used for guideline development, as the risk of bias is 
minimised due to the explicit methods used.138-141 
The process involved for a systematic review includes the following steps137,142-145: 
1. Formulation of a review question 
a. Often formulated using PICO (population, intervention, comparison 
and outcome) concepts, with keywords and synonyms extrapolated 
from this.138  
2. Development of an a priori study protocol (the study protocol for this 
systematic review was published in 2019146) 
a. Including predetermined inclusion and exclusion criteria, clear 
explanation of the planned search, how evidence will be critically 
appraised and synthesised. 
b.  Development of a comprehensive search strategy. 
3. Locating the evidence 
a. Searching of predefined databases using appropriate database 
headings and field terms. 
b. Searching for grey/unpublished data.  
c. Hand searching reference lists of included evidence. 
d. The search should be reported and reproducible. 
4. Assessing the methodological quality of included studies  
a. Critically appraising to ascertain risk of bias. 
5. Synthesising the evidence  
a. This is often done using meta-analysis (statistical method that 
combines the results from different studies, and providing an overall 
effect estimate of the intervention137,147). 
6. Interpreting the findings  
a. Exploring reasons for heterogeneity of results across a study. 
 
There are two major advantages of systematic reviews over clinical trials. 
Combining the data from a number of studies increases the statistical power, which 
increases the probability of identifying a true effect, if one is present.  This is 
particularly useful for interventions with rare adverse outcomes or where data are 
sparse, which is the case in the management of occult pneumothoraces.  The second 
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advantage is that systematic reviews produce generalisability through demonstrating 
similar effects over a variety of clinical settings and countries.148  Generalisability of 
adverse effects and treatment harms can be further shown with the addition of 
observational research.  Observational research has been shown to have no 
difference to RCTs in estimates of risk of adverse events, and therefore provides 
essential data when investigating adverse events and treatment harms.149,150 
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Chapter 2: Methods 
This chapter presents the methods used in the conduct of the systematic review, 
incorporating the inclusion criteria, search strategy, methods for critical appraisal, 
data extraction and synthesis. 
An a priori study protocol was completed and published to guide the conduct of this 
systematic review146 (see also Appendix 1).  This review adheres to the JBI 
methodology for systematic reviews of effectiveness.143  
 
2.1 Inclusion criteria 
2.1.1 Participants  
The review considered studies that included stable patients of any age, diagnosed 
with a traumatic occult pneumothorax on thoracoabdominal CT scan, who have 
undergone mechanical ventilation.  The mechanical ventilation could occur in the 
emergency department, intensive care unit or as part of the provision of general 
anaesthesia.  
All ages were included as the management of occult pneumothorax is similar in 
adults and paediatric patients.  There may be differences in how their ventilation is 
managed, however there is also no standard ventilation mode in adult patients 
throughout ICU and anaesthetics, therefore inclusion occurred irrespective of these 
potential differences. 
Including only stable patients is important as an unstable patient with a known or 
suspected pneumothorax would receive bilateral ICCs as part of the management of 
their instability to rule out tension pneumothorax as a potential cause, thereby 
making conservative management impossible. 
The review considered occult pneumothoraces caused by either blunt or penetrating 
trauma, as the mechanism causing the pneumothoraces is similar.  Details of the 
mechanisms can be found in ‘Introduction’ (see Section 1.2.4.3). 
Occult haemopneumothoraces were excluded from the review as the haemothorax 
would add further confounding factors to the review.  This is due to the increased 
risk of ICC insertion and empyema with haemothorax present. 
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2.1.2 Intervention of interest  
The review considered studies that evaluated conservative management for occult 
pneumothorax.  Conservative management includes clinical observation, serial 
examination and/or serial chest X-ray. 
2.1.3 Comparator  
The review considered studies that compared the intervention to ICC insertion for 
occult pneumothorax.  The ICC can be inserted via any method, including the 
Seldinger technique or blunt dissection (see Section 1.4.1). 
2.1.4 Types of studies 
The review considered both experimental and quasi-experimental study designs, 
including RCTs and non-RCTs. In addition, comparative observational studies, 
including prospective and retrospective cohort studies, were considered for 
inclusion.  Observational data was included as it is essential to provide a full picture 
when investigating harms and adverse effects of treatment. 
 
2.2 Outcomes  
2.2.1 Primary outcomes  
The primary outcomes of interest were progression of pneumothorax (seen on chest 
X-ray), ICC insertion for any reason, incidence of tension pneumothorax (diagnosed 
clinically) and incidence of pneumonia/empyema. 
2.2.2 Secondary outcomes 
The secondary outcomes of interest were all-cause mortality, ICC insertion (tension 
pneumothorax), ICC insertion (progression to simple pneumothorax), ICC insertion 
(non-pneumothorax reasons), length of stay in hospital and intensive care (in days), 
duration of mechanical ventilation (in days), duration of ICC dwelling (in days), 
haemodynamic instability (measured as need for vasopressor support), pain 
(measured by a validated pain scoring tool for sedated ICU patients such as 
Behavioural Pain Scale [BPS] and Critical-Care Pain Observation Tool 
[CPOT]),151,152 and analgesia requirements (measured in parenteral morphine 
equivalents per 24 hours as per Australian and New Zealand College of 
Anaesthetists [ANZCA] opioid conversion153). 
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This review also considered adverse events/complications of ICC insertion 
(measured as composite and breakdown, including malpositioning, infection, organ 
injury and vascular injury). 
 
2.3 Review method 
2.3.1 Search strategy  
The search strategy followed a three-step approach and aimed to locate both 
published and unpublished studies.143  This process commenced in February 2019. 
Step 1 involved an initial limited search of PubMed (MEDLINE) to identify articles 
on the topic, using the terms “occult pneumothorax” AND “mechanical ventilation”.   
The text words contained in the titles and abstracts of relevant articles were 
analysed.  In addition, the index terms used to describe the articles were reviewed 
and relevant MeSH terms (PubMed’s controlled vocabulary thesaurus) were 
searched for.  The key text words and MeSH terms were then used to develop a full 
search strategy for PubMed.  The final step was to adapt the PubMed search 
strategy, including all identified keywords and index terms, for the following 
databases: Embase, CINAHL (EBSCO), Web of Science and Cochrane Central 
Register of Controlled Trials.  Sources of unpublished studies were searched for in 
the following registries: International Clinical Trials Registry (ICTR), Australian 
and New Zealand Clinical Trials Registry (ANZCTR) and ClinicalTrials.gov.  
The full search strategy was completed on 17th June 2019.  There were no date or 
language limits applied to the search.  Details of the searches conducted in each 
database and registry are detailed in Appendix 2.  This includes logic grids and full 
search strategies.  Finally, the reference lists of all studies selected for inclusion 
were screened for additional studies.  
2.3.2 Study selection  
Following the search, all identified records were collated and uploaded into Endnote 
X8.2 (Clarivate Analytics, PA, USA)154 and duplicates removed.  Titles and 
abstracts were then screened twice by one reviewer (JS) for assessment of eligibility, 
according to the inclusion criteria for the review.  Potentially relevant studies were 
retrieved in full and their citation details imported into the JBI System for the 
Unified Management, Assessment and Review of Information (JBI 
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SUMARI2017) (JBI, Adelaide, Australia).155 The full texts of selected citations were 
assessed in detail against the inclusion criteria by one reviewer (JS), and 
uncertainties that arose during inclusion were resolved through discussion with a 
second and third reviewer (PS, EA).  Reasons for exclusion of full text studies that 
did not meet the inclusion criteria were recorded (see Appendix 3). 
2.3.3 Assessment of methodological quality  
Eligible studies were critically appraised by two independent reviewers (JS, AV) at 
the study level for methodological quality in the review using standardised critical 
appraisal instruments from JBI for experimental and comparable cohort studies143 
(see Appendix 4).  Nine authors of papers that were published within the last ten 
years (i.e. after 2009) were contacted to request missing or additional data for 
clarification (see Appendix 5).  Disagreements that arose between reviewers were 
resolved through discussion.  A decision was made a priori146 (see Appendix 1), 
given the expected limited quantity of research in this field, to not exclude studies 
based on low methodological quality and high risk of bias, rather, all studies were 
included to ensure full consideration of the available dataset in subsequent 
analyses.156 
2.3.4 Data extraction  
Data were extracted from studies included in the review using a modified 
standardised data extraction tool143 (see Appendix 6).  The data extracted included 
specific details about the population (age, sex and injury severity score [ISS]), study 
methods, and the intervention and comparator (including insertion technique, where 
possible), and outcomes of significance to the review objective (see Section 2.2).  
Nine authors of papers that were published within the last ten years (i.e. after 2009) 
were contacted to request missing or additional data (see Appendix 5). 
2.3.5 Data synthesis 
Selection of an appropriate meta-analytical model was complicated due to the sparse 
data and rare events observed for the majority of outcomes.  When there are zero 
event counts in studies, the Mantel-Haenszel (M-H) model requires the use of a 
continuity correction (default is 0.5 in most statistical software); this has a marked 
impact where there is sparse data throughout an analysed dataset leading to a biased 
calculated effect size.157,158  The Peto odds ratio (POR) method is well suited to rare 
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events (<1%) as it does not require a continuity correction for single arm zero event 
studies, however it does not perform well when there is an imbalance in the number 
of participants between groups157-159 (which is common with observational studies).  
To maintain the same meta-analytical model that could account for sparse data and 
the presence of zero values and unbalanced groups throughout all the analyses, a 
logistic regression model was chosen after discussion with statisticians (KH, JL, JB).  
Logistic regression has been shown to perform well with rare events and also with 
group imbalance157-159 and does not require continuity correction.   
Studies, where possible, were pooled in statistical meta-analysis using Stata V15 
(Stata Corp LLC, Texas, USA).160  Effect sizes were expressed as odds ratios and 
their 95% confidence intervals calculated for analysis.  A mixed-effects logistic 
regression model using a one stage approach was used for the meta-analysis161-163; 
this model takes into account heterogeneity between studies when using a one stage 
approach.161,164  The impact of the chosen model on the effect size estimate was 
explored using sensitivity analyses.163  Other models used included the M-H random 
effects model and POR for RCT data, as the data from RCTs were balanced and had 
less zero events.  For cohort studies, the M-H fixed-effects model and POR were 
used as there was a lower incidence of events in the cohort studies and many of the 
cohort studies were unbalanced.  The M-H fixed-effects model was used for cohort 
studies, as the random-effects model has been shown to produce biased effect sizes 
when there are rare or sparse data.159  Analyses with the M-H and POR models were 
performed with RevMan V5.3 (Copenhagen: The Nordic Cochrane Centre, 
Cochrane).165  Heterogeneity for M-H and POR was assessed statistically using the 
standard χ2and I2 test.  The logistic regression, M-H and POR odds ratios, and 95% 
confidence intervals were presented together, where possible, for each outcome to 
aid visual inspection of the results of the various methods used for data analysis. 
Meta-analysis of experimental and observational data were completed separately for 
each outcome.  In all analyses, raw event counts were utilised as adjusted estimates 
were not provided.  Impact of sample size and event counts, that is, studies that 
appeared to have a marked influence in terms of their contribution to the overall 
effect in any analysis, were explored using sensitivity analysis.  A funnel plot was 
not generated as there were less than 10 studies in all the meta-analyses.166  Any 
study that did not have complete data for a given outcome was not included in the 
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meta-analysis for that outcome; rather, the available study results were included in a 
narrative summary, where appropriate.  The study by Fulton & Bratu167 was not 
included in the statistical analysis as their planned ‘ICC group’ had no patients to 
include; it has been included in the narrative summary.  Where statistical pooling 
was not possible, the findings are presented in narrative form, including tables and 
figures to aid in data presentation, where appropriate.    
2.3.6 Assessing certainty in the findings 
Due to the paucity of data and the required analyses necessitating calculation of the 
odds ratio, assessment of certainty in the findings using Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) processes, 
including Summary of Findings tables, was not progressed as intended a priori.146 
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Chapter 3: Results 
This chapter presents the results of the systematic review.  It includes results of the 
search processes, study selection, assessment of methodological quality and 
characteristics of included studies.  The findings for each outcome are also reported 
in this chapter. 
 
3.1 Searching and study selection 
The search for published studies returned a total of 3055 citations from the following 
databases (PubMed 595; Embase 1694; Cochrane Central Register of Controlled 
Trials 103; Web of Science 566; CINAHL 97).  A search of clinical trial registries to 
locate additional unpublished studies returned 301 citations (ClinicalTrials.gov 110; 
International Clinical Trials Registry (ICTR) 104; Australian and New Zealand 
Clinical Trials Registry (ANZCTR) 87).  From these citations, 1126 duplicates were 
identified and removed (see Figure 3.1). 
The titles and abstracts of the remaining 2230 unique citations were screened twice 
against the inclusion criteria (see Section 2.1). This led to 2210 citations being 
excluded, leaving 20 citations for full-text retrieval and review.  One of these initial 
20 citations was unavailable as the trial was still ongoing.168  Two further 
articles169,170 of interest were identified from hand searching the reference lists of the 
19 full text articles.  Overall, 21 full text articles were assessed for eligibility.  Seven 
of the 21 articles were excluded following full-text review (see Figure 3.1 and 
Appendix 3).  One of the articles171 was a pilot of a later published study65; the 
participants were included in the later study.  Data from this article171 has been 
combined with the later study65 and treated as one record.  One article172 was a 
commentary of a previously published RCT.  Two studies were excluded64,173 as 
they had no planned comparator group, whereas four were excluded as they did not 
report pertinent data (Johnson174 – no occult pneumothoraces, Lamb et al.175 – no 
ventilated patients in observation group, Kaiser et al.176 – management and outcomes 
not included, Wolfman et al.177 – relevant data missing).  One further article178 was 
excluded following attempts to contact the authors were unsuccessful (see Appendix 
5), and as the published data did not include defined occult pneumothoraces.  
Overall, 12 studies were included (13 articles), comprising three RCTs and nine 
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cohort studies (two prospective and seven retrospective), with a total of 311 


























* 13 studies/14 publications  
**12 studies/13 publications 
Figure 3.1: PRISMA flow diagram of the study selection and inclusion process 
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3.2 Methodological quality of included studies  
The methodological quality of the included studies is presented in Table 3.1 for 
RCTs and Table 3.2 for cohort studies.  An ‘unclear’ rating indicates that the 
relevant details could not be found in the articles and the data could not be 
ascertained  (either due to the author being uncontactable or unable to provide 
additional information, or the article having been published over 10 years ago) (see 
Section 2.3.3 and Appendix 5). 
 
Of the three included RCTs, it was clear in two trials63,65 that appropriate 
randomisation was used and that allocation was concealed (Table 3.2, Questions 1 
and 2).  Brasel et al.179 provided insufficient detail about how they randomised 
patients and how allocation was concealed.  Treatment groups were similar in two 
studies65,179 (Table 3.2, Question 3); Enderson et al.63 had differences in sex 
(conservative management group 77% male versus 95% in ICC group) and age 
(mean age 35.8 ± 4.0 in conservative management group versus 39.4 ± 3.7 in ICC 
group).  Due to the nature of the intervention, none of the trials could blind either 
patient or clinician (Table 3.2, Questions 4 and 5).  It was unclear in all three 
studies63,65,179 if assessors were blinded to treatment allocation (Table 3.2, Question 
6).  It was clear in Kirkpatrick et al.65 that treatment groups were treated identically 
other than the intervention of interest.  In Enderson et al.63 it was unclear if there 
were differences in treatment of the two groups other than the intervention of 
interest.  In the study by Brasel et al.179, the two groups were treated differently.  
The conservative management group had signs above their bed stating they had an 
undrained pneumothorax (Table 3.2, Question 7).  Follow-up was complete in all 
three studies63,65,179 (Table 3.2, Question 8).  All participants63,65,179 were analysed in 
the groups to which they were allocated (Table 3.2, Question 9).  It was unclear in 
two studies63,179 if outcomes were measured the same way in both groups and in a 
reliable way.  Brasel et al.179 and Enderson et al.63 did not state how they measured 
progression of pneumothorax (Table 3.2, Questions 10 and 11).  Appropriate 
statistical analysis was completed in all three trials63,65,179 (Table 3.2, Question 12).  
All three trials63,65,179 had appropriate study designs (Table 3.2, Question 13).  Two 
RCTs63,179 rated low (5 and 6 out of 13) due to the uncertainty of many questions 
which were not clarified with the authors due to the time lapse since publication of 
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the articles.  The study by Kirkpatrick et al.65 had more clarity in the reporting of its 
methodology due to the standardised reporting of RCT methods based on the 
Consolidated Standards of Reporting Trials (CONSORT) guidelines180, which 
facilitated assessment of the conduct of the trial and thus was rated 10 out of 13 for 
methodological quality. 
Table 3.1: Methodological quality of randomised controlled trials included in this review 
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Total 
Brasel et 
al.179 U U Y N N U N Y Y U U Y Y 5 
Enderson et 
al.63 Y Y N N N U U Y Y U U Y Y 6 
Kirkpatrick 
et al.65 Y Y Y N N U Y Y Y Y Y Y Y 10 
Total Y 
score (%) 66.6 66.6 66.6 0.0 0.0 0.0 33.3 100 100 33.3 33.3 100 100 
Studies are rated as Yes (Y), No (N) or Unclear (U) for each question.  See Appendix 4 for explanatory details of critical 
appraisal tools. 
Appraisal questions for randomised controlled trials (RCTs): 
1. Was true randomisation used for assignment of participants to treatment groups? 
2. Was allocation to treatment groups concealed? 
3. Were treatment groups similar at baseline? 
4. Were participants blind to treatment assignment? 
5. Were those delivering treatment blind to treatment assignment? 
6. Were outcome assessors blind to treatment assignment? 
7. Were treatment groups treated identically other than the intervention of interest? 
8. Was follow up completed and if not, were differences between groups in terms of their follow up adequately 
described and analysed? 
9. Were participants analysed in the groups to which they were randomised? 
10. Were outcomes measured in the same way for treatment groups? 
11. Were outcomes measured in a reliable way? 
12. Was appropriate statistical analysis used? 
13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomisation, 
parallel groups) accounted for in the conduct and analysis of the trial) 
 
For cohort studies, there were two prospective and seven retrospective studies.  
Six16,170,181-184 had similar populations.  Fulton & Bratu167 did not recruit any patients 
for their planned ICC group.  Zhang et al.10 and Collins et al.169 reported a 
significant difference in the age of patients in the two groups (Zhang: conservative 
management 25 years mean age versus ICC 34 years mean age, p = 0.027; Collins: 
conservative management median 24 years versus ICC median 44.5years) (Table 
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3.1, Question 1).   The exposure was measured in a consistent and reliable way in all 
cohort studies10,16,167,169,170,181-184 (Table 3.1, Questions 2 and 3).  In seven 
studies10,16,167,170,182-184, it was clear if confounding factors had been identified (Table 
3.1, Question 4), with five10,167,170,183,184 explaining how they dealt with these 
confounding factors (Table 3.1, Question 5), however the studies did not adjust 
effect estimates for the stated confounding factors.  Participants in all the 
studies10,16,167,169,170,181-184 were free of the outcome at the beginning of the study 
(Table 3.1, Question 6).  Seven studies10,167,170,181-184 were clear on how they 
measured outcomes and did so in a reliable way (Table 3.1, Question 7).  Seven 
studies10,167,170,181-184 stated their follow-up times (Table 3.1, Question 8) and 
eight10,167,169,170,181-184 stated their follow-up rates (Table 3.1, Question 9).  It was 
clear in three studies10,167,182 how loss to follow-up was addressed (Table 3.1, 
Question 10).  In eight studies10,16,169,170,181-184, appropriate statistical methods were 
used (Table 3.1, Question 11). Overall, five10,170,182-184 of the nine cohort studies 
were rated 10 out of 11 for methodological quality.   
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Table 3.2: Methodological quality of cohort studies included in this review 
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Total 
Ball et 
al.170 Y Y Y Y Y Y Y Y Y U Y 
10 
Collins 





N Y Y Y Y Y Y Y Y Y U 9 
Holmes 
et al.181 Y Y Y U U Y Y Y Y N Y 
8 
Lee et 





Y Y Y Y U Y Y Y Y Y Y 10 
Notrica 
et al.183 Y Y Y Y Y Y Y Y Y N Y 
10 
Wilson 
et al.184 Y Y Y Y Y Y Y Y Y U Y 
10 
Zhang et 





66.6  100 100 77.7 55.5 100 77.7 77.7 88.8 33.3 88.8 
Studies are rated as Yes (Y), No (N) or Unclear (U) for each question.  See Appendix 4 for explanatory details of critical 
appraisal tools. 
Appraisal questions for cohort studies: 
1. Were the two groups similar and recruited from the same population? 
2. Were the exposures measured similarly to assign people to both exposed and unexposed groups? 
3. Was the exposure measured in a valid and reliable way? 
4. Were confounding factors identified? 
5. Were strategies to deal with confounding factors stated? 
6. Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? 
7. Were the outcomes measured in a valid and reliable way? 
8. Was the follow up time reported and sufficient to be long enough for outcome to occur? 
9. Was the follow up complete, and if not, were reasons to los to follow up described and explored? 
10. Were strategies to address incomplete follow up utilised? 
11. Was appropriate statistical analysis used? 
 
3.3 Characteristics of included studies  
3.3.1 Study populations 
Details of the participants’ baseline characteristics (age, sex and injury severity 
score [ISS]) are presented in Table 3.3.  Non-statistically significant differences 
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were seen in the baseline characteristics of the following cohort studies.  Collins et 
al.169 (age: conservative management median 24 versus ICC median 44.5), Llaquet 
Bayo et al.182 (ISS: conservative management median 33 versus ICC median 38.5, p-
value 0.245) and Wilson et al.184 (age: conservative management median 44 versus 
ICC median 29, p-value 0.17).  Statistically significant differences were seen in the 
baseline characteristics of Zhang et al.10 (age: conservative management median 25 
versus ICC median 34, p-value 0.027).  Other than the above differences, all study 
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Table 3.3: Baseline characteristics of study populations 
Study Group Age, years Male sex, n (%) ISS 
Ball et al.170 
Conservative Mx Not specified Not specified Not specified 
ICC Not specified Not specified Not specified 
Brasel et al.179 * 
Conservative Mx 37.5 (average) Not specified 19.14 (average) 
ICC 39.5 (average) Not specified 22.41 (average) 













Enderson et al.63 * 
Conservative Mx 
35.8 ± 4.0 (16-
88) 




26.3 ± 2.7(9-66) 
Mean ± SEM 
(range) 
ICC 
39.4 ± 3.7 (19-
79) 




26 ± 2.5 (10-50) 
Mean ± SEM 
(range) 






Holmes et al.181 
Conservative Mx Not specified Not specified Not specified 
ICC Not specified Not specified Not specified 
Kirkpatrick et 
al.65 












p -value 0.344 1.00 0.271 




















p -value 0.559  0.245 
Notrica et al.183* Total 11.6 ± 5.9 
Average 
Not specified 22.5 ± 10.9 
average 













p -value 0.17 0.34 0.10 













p -value 0.027 0.251 0.436 
ISS – injury severity score; Mx – management; ICC – intercostal catheter, IQR – interquartile range, SEM – standard error of 
mean 
* Characteristics of whole study population, not specific to ventilated subgroup of patients 
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The three RCTs63,65,179 included adults only.  Of the nine cohort studies, 
three167,181,183 included only paediatric patients, one included only adults182, one169 
did not specify the age range, and four10,16,170,184 included all ages (see Table 3.4).   
Two RCTs63,65 included patients with blunt and penetrating trauma, the remaining 
RCT179 excluded patients with penetrating trauma.  Five cohort studies included 
only blunt trauma10,16,169,181,184 and four included both blunt and penetrating 
trauma167,170,182,183 (see Table 3.4).  One RCT65 recruited only mechanically 
ventilated patients, while two63,179 recruited patients regardless of their mechanical 
ventilation status, and recruited a proportion of mechanically ventilated patients 
within both arms of the studies. 
One cohort study167 included only mechanically ventilated patients, the remaining 
eight10,16,169,170,181-184 included patients receiving mechanical ventilation and patients 
who were breathing without mechanical support (see Table 3.4). 
 
3.3.2 Geographical location  
Two RCTs were conducted in the USA63,179 and one in Canada.65 The majority of 
cohort studies (six out of nine) were conducted within North America (three in 
Canada167,170,184 and three in the USA169,181,183).  The three trials conducted outside 
of North America were in Hong Kong16, Singapore10 and Spain182, respectively. 
Further details indicating the hospitals in which the studies were performed can be 
found below (see Table 3.4).  Two trials were multicentre RCTs65,179 and Enderson 
et al.63 recruited patients from one hospital.  Two cohort studies183,184 collected data 
from multiple hospitals, the remaining seven10,16,167,169,170,181,182 collected data from 
single sites (see Table 3.4). 
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Table 3.4: Characteristics of included studies 
Study  Setting/ 
context 
Participant characteristics Participants Outcomes measured Description of main results/ 
author’s conclusion 
Comments 

















All trauma patients with ISS 
>12, who had CT scan showing 
occult PTX  
Age:  
All ages   
Insertion technique:  
Blunt dissection with 28 or 32F 
ICC  
Trauma type:  
Blunt and penetrating  
CT scanner:  
Chest/abdomen/pelvis or 
abdomen/pelvis, LightSpeed 




49 patients with 
occult PTX 











ICU and hospital 
length of stay 
Ventilation days 





No serious complications 
resulted from conservative 
Mx, however 2 patients in the 
conservative Mx group 
required an ICC for 
progression of PTX. 
22% of patients with ICCs had 
tube related complications or 
required repositioning. 
 
Authors concluded that due to 
ICC insertion often having 
adverse consequences, 
rethinking an algorithmic 
policy of prophylactic 




In the conservative Mx 
group there was one 
patient requiring ICC 
insertion for progression of 
PTX.    
In the ICC group there 
were 3 complications (1 
malpositioning and 2 
vascular injuries). 
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Occult PTX incidence: 
15% (49/338) in all seriously 
injured patients who had 
thoraco-abdominal CT scans, 
6% (49/751) among all trauma 
registry patients. 
















All blunt trauma patients with 
occult PTX seen on abdominal 
CT  
Age:  
Over 18 years   
Insertion technique: 




Abdominal, General Electric 




39 patients with 
44 occult PTX  















Placement of ICC 
Length of stay 
Ventilator days 
No difference in overall 
complication rate.  
No patient had respiratory 
distress related to the occult 
PTX or required emergent 
ICC placement. 
20% of patients conservatively 
managed required chest tube 
placement. 
Authors concluded that 
conservative Mx is safe 






PTX progression occurred 
in 2 patients in the 
conservative Mx group 
(requiring ICC placement) 
and 3 patients in ICC 
group (not requiring 
further ICC).  
No tension PTX in either 
group. 
 
Reason for ventilation: 
3 patients in each group 
had ventilation for 
procedure only.  




Peak pressure limits 30-35 
mmHg 
Occult PTX incidence: 
5.9% (98/1669) receiving 
abdominal CT scan, 1.9% 
(98/5126) among all blunt 
trauma patients. 
6 in each arm ventilated 
for greater or equal to 1 
day.  

















Trauma patients undergoing CT 
scanning of abdomen and pelvis 
within 1 hour of arrival showing 








Abdomen/pelvis, model not 
specified 
Total: 
26 patients with 
27 occult PTX 










Hospital and ICU 
length of stay 
ICC dwell time 
Complications 
Mortality  
Identified 2 significant 
complications of ICC insertion 
(intercostal artery laceration 
and self-removal).  
Conservative Mx produced 2 
complications (one delayed 
PTX and one delayed 
haemothorax with possible 
delayed PTX), both resolved 
with placement of ICC. 
No patient developed tension 
PTX. 
2 patients died, both 
considered unrelated to ICC or 
occult PTX. 
Ventilated subgroup: 
There was one patient in 
each group requiring ICC 
placement (ICC group: 
progression of PTX due to 
self-removal of ICC, 
conservative Mx group: 
non-PTX related reasons).  
1 patient in each group 
died. 
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Trauma patients undergoing 





Blunt dissection 36F 
Trauma type: 
Blunt and penetrating 
CT scanner: 
Abdominal scans, model not 
specified   
 
Total: 
40 occult PTX 










Major complications:  





Hospital and ICU 
length of stay  
9 patients had complications 
in conservative Mx group (8 
progression of PTX including 
3 tension PTX, 1 pneumonia, 
1 empyema, 3 atelectasis) and 
8 patients in ICC group (1 
pneumonia, 8 atelectasis). 
All progression of PTX 
happened to patients receiving 
mechanical ventilation. 
Authors concluded the results 
suggested that patients with 
occult PTX requiring 
mechanical ventilation are at 
significant risk for progression 
of their PTX and development 
of tension PTX. Therefore, 
ICC should be used in all 






In conservative Mx group 
8 patients had progression 
of PTX requiring ICC 
placement (including 3 
tension PTX), 1 developed 
empyema following 
insertion of an ICC for 
progression of PTX.   
No PTX progression 
occurred in ICC group. 
 
Reason for ventilation: 
All 15 in conservative Mx 
group and 10 out of 12 in 
the ICC group had an 
operation.  However not 
stated if ventilation was 
required pre/post 
operation.  
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Occult PTX incidence: 
5.6% (40/709) receiving 
abdominal CT scan, 1.2% 
(40/3261) among all blunt 
trauma patients. 














Jan 2001 - Dec 
2011 
Inclusion criteria: 
Mechanically ventilated, ISS 
score >12 and a diagnosis of 
PTX (presence of occult PTX 
determined with chart review) 
Age: 




Blunt and penetrating to be 
included (however all patients 
had blunt) 
CT scanner: 
Abdomen +/- thorax, 
unspecified model 
Total: 
ICC group: 0 
Conservative Mx 
group: 19 (15 
children) 
 
Placement of ICC 
Progression of PTX 
Complications 
All patients were successfully 
managed without the need for 
ICC. 
Authors concluded results 
suggest that occult PTX in 
paediatrics can be managed 
without ICC. 
 
Occult PTX Incidence: 
3.8% (19/496) children 
admitted to paediatric ICU and 
receiving MV. 
There was no progression 
of PTX and no ICC 
insertions required in the 
conservative Mx group. 
 
Reason for ventilation: 
6 of 19 patients had less 
than 24 hours ventilated.  
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Blunt trauma patients 
undergoing abdominal CT   
Age: 





CT scanner:  
Abdominal scans, either 4th 
generation Toshiba-900 (5mm 
slices) or helical CTi by General 
Electric (3mm if <10kg, 5mm if 
10-50kg, 7mm if >50kg) 
Total: 
12 occult PTX (11 
patients) 






ICC group: 1 
Conservative Mx 







Incidence of occult PTX in 
paediatric blunt trauma is low. 
ICC is infrequently required 
for occult PTX.  Further RCT 
required. 
 
Occult PTX incidence:  
2.2% (12/538) children 





No patient in either group 
had respiratory or 
haemodynamic 











Patients with occult PTX 
identified on CT  
Age: 
Over 18 years 
Insertion technique: 
Total: 







distress (defined as 
acute change from a 
"stable" baseline 
clinical state that 
15% ICC complication and 
15% had suboptimal ICC 
positioning.  
Risk of respiratory distress 
was similar between two 
groups. 
ICC insertion was required 
in 10 patients in 
conservative Mx group (1 
tension PTX, 3 progression 
to simple PTX, 6 for non-
PTX related reasons) and 
in 7 patients in ICC group 







Oct 2006 - Feb 
2012 
Blunt dissection or Seldinger 
technique 
Trauma type: 
Blunt and penetrating 
CT scanner: 
Any site, model not specified   
  
required the urgent 
placement of an ICC, 








ventilation or prone 
ventilation, or 
documentation of an 
adverse respiratory 
event in the medical 
record)  
Secondary outcomes 
were divided into 
respiratory related 
(requirement for ICC, 
tracheostomy, ICC 
dwell time, ventilator 
associated pneumonia 
There were 3 times more 
conservative Mx failures (24% 
vs 8%) among conservative 
Mx for “prolonged mechanical 
ventilation” versus ventilation 
for a general anaesthetic only 
 
Authors concluded that the 
results suggest that occult 




mechanical ventilation just for 
an operation, although one 
third of those requiring a week 
or more of ICU care received 
ICC, and tension PTXs still 
occurred.  Complications of 
pleural drainage remained 
unacceptably high. 
(2 for progression to 
simple PTX, 5 for non-
PTX related reasons).  
Mortality was 4 in each 
group.  
ICC complications 
occurred 11 times in ICC 
group (10 malpositioning).  
Incidence of 
pneumonia/empyema was 
13 in observed group and 7 
in ICC group. 
 
Reason for ventilation: 
13 in conservative Mx 
group and 12 in the ICC 
group had ventilation for 
an operation only.  
37 in conservative Mx 
group and 28 in ICC group 
had “prolonged 
ventilation”. 
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or adult respiratory 
distress syndrome) or 
global (death, 
ventilator days, ICU 
and hospital length of 
stay)   
Drainage 
complications 














Jan 2006 - Dec 
2007 
Inclusion criteria: 
Severely injured patients with 
blunt chest trauma undergoing 
thoracic CT found to have 
occult PTX 
Age: 






Thoracic CT, unspecified model   
Total: 
44 occult PTX (36 
patients)  






ICC group: 8 
Conservative Mx 
group:  8 
 
Nature and number of 
complications 
Mortality 
Patients that received 
mechanical ventilation in the 
trauma room were more 
severely injured (ISS 48 vs 
33) than those that received 
mechanical ventilation in the 
operating room.  All those 
patients who were ventilated 
in trauma room received an 
ICC. 
No complications associated 
with conservative Mx. 
Since ICC is not without 
complication it may be 
possible to extend the concept 
Ventilated subgroup: 
There were no 
complications or mortality 
in the conservative Mx 
group.  
In the ICC group there was 
1 major complication 
(empyema) and 3 minor 
complications (persistent 
intercostal neuralgia and 
wound infection). 
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of conservative Mx to those 
who received ventilation in 
trauma room within this study. 
 
Occult PTX incidence: 
36.9% (44/119) significant 
blunt chest trauma undergoing 
CT scan. 










Level 2 teaching 
hospital 
Time period: 
March 2006 - 
Dec 2013 
Inclusion criteria: 
Polytrauma patients diagnosed 
with occult PTX and admitted to 
critical care section of hospital  
Age: 




Blunt and penetrating 
CT scanner: 
Thoracic and abdominal, model 
not specified   
Total: 
126 occult PTX 










Success rate of 
conservative 
management 
(considered failed if 
ICC required) 
Tension PTX rate 
Hospital and ICU 





infection or bleeding 
11% (8/73) failure of 
conservative Mx, 19% (3/16) 
in ventilated subgroup.  
8 cases required ICC insertion: 
5 for haemothorax, 3 for 
progression of PTX.   1 was 
prophylactical placed pre 
surgery. 
3 patients presented 
complications associated with 
the drainage (2 inserted into 
subcutaneous tissue; 1 lost 
position).  
Ventilated subgroup: 
In the conservative Mx 
group 3 patients required 
ICC placement (1 for 
progression of PTX, 2 for 
non-PTX related reasons).  
Mortality was 3 in 
conservative Mx group 
and 8 in ICC group. 
2 complications of ICC in 
ventilated patients. 
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  Concluded that treatment of 
choice for occult PTX is 




Occult PTX incidence:  
11.6% (126/1087) polytrauma 
patients admitted to critical or 
semi-critical care sections of 
the hospital. 














Patients with traumatic occult 
PTX 
Age: 
Under 18 years 
Insertion technique: 
Discretion of attending surgeon 
Trauma type: 
Blunt and penetrating 
 
Total: 
52 occult PTX (51 
patients) 






ICC group: 1 
Placement of ICC 
Hospital and ICU 
length of stay 
Ventilator days 
Indication for ICC 
Mortality 
Complications 
Average tidal volume 
and peak inspiratory 
pressure also 
measured 
Only 2% (1/49) failed 
conservative Mx.  2 PTX 
progressed in size in 
conservative Mx group, only 
one required ICC. 
Authors concluded that this 
demonstrated safety of 
conservative Mx of occult 
PTX less than 16.5mm. 
The physical discomfort, 
potential morbidity and risk of 
Ventilated subgroup: 
Neither group had 
progression of PTX nor 
need for ICC insertion. 
 
Reason for ventilation: 
4 patients in conservative 
Mx group and 1 in ICC 
group underwent an 
operation. 
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CT scanner: 
Unspecified site and model   
Ventilation settings:  
Average TV 7.2+/- 1.1ml/kg, 
average peak inspiratory 




complications of ICC must 
now be compared to the 
relative safety of conservative 
Mx. 














Oct 1994 - 
March 2003 
Inclusion criteria: 
Blunt trauma patients with ISS 
>12 and PTX diagnosis (occult 
PTX was identified through 








Site or model not specified   
Total: 
68 occult PTX 










Hospital length of 
stay 
Mortality 
Intervention and time 
to intervention (ICC 




There were no instances of 
PTX progression or tension 
PTX in the observation group. 
Length of stay was longer in 
ICC group (10 vs 7 days, 
p=0.01), mortality similar. 
Conclusion from authors: 
conservative Mx may be safe. 
 
Occult PTX incidence: 
3.6% (68/1881) blunt trauma 
patients admitted. 
Ventilated subgroup: 
No progression of PTX or 
tension PTX in either 
group. 
 
Reason for ventilation: 
In conservative Mx group, 
16 patients had an 
operation.  10 of these 
received ventilation only 
for the operation. 
Page 64 of 146 
 










Tan Tock Seng 
Hospital 
Time period: 
Jan 2009 - Dec 
2012  
Inclusion criteria: 
Patients in trauma database with 
an CT scan visualising the 
thorax partially or fully showing 
occult PTX.  
Age: 






64 slice multidetector CT, any 
CT visualising the thorax 
  
Total: 
83 occult PTX 










Hospital length of 
stay 
Subsequent 






Increased hospital length of 
stay for ICC group (13 days 
versus 5.5, p =0.008). 
No difference in mortality.  
4/48 conservatively Mx 
patients had progression of 
PTX requiring ICC. 
ICC group 7/35 had 
complications and 3/35 had 
progression of PTX. 
ICC group were nearly 10 
times more likely to have a 
complication (OR 9.92). 
Authors advocated for 
conservative Mx in light of 
inherent ICC complications. 
 
Occult PTX Incidence:  
5.3% (83/1564) Ten Tock 
Seng Hospital trauma 
database. 
Ventilated subgroup: 
In the conservative Mx 
group, 1 patient required 
ICC placement for 
progression of PTX. 
PTX – pneumothorax; Mx – management; ICC – intercostal catheter; MV – mechanical ventilation; ICU – intensive care unit; CT – computed tomography; ISS – injury severity score; TV – tidal volume  
Page 65 of 146 
 
3.3.3 Study design and interventions  
The majority of the cohort studies (seven out of nine) were retrospective 
design.10,16,167,169,170,182,184  The remaining two were prospective181,183 and both 
included exclusively paediatric patients.  Further details can be seen in Table 3.4. 
The intervention in all studies10,16,63,65,167,169,170,179,181-184 was conservative 
management, which involved not inserting an ICC and monitoring clinically and/or 
radiographically for signs of progression of pneumothorax.  Different terms were 
used throughout the different studies (e.g. observation, expectant management).  The 
comparator group was ICC insertion.  The insertion technique for the ICC was 
specified in all RCTs; two blunt dissection63,179 and one blunt dissection or Seldinger 
technique.65  In regards to cohort studies, three specified the technique: blunt 
dissection170, ‘at the operator’s discretion’183 and inserted by ‘standard fashion’.169  
The insertion technique was unspecified in the remaining studies10,16,167,181,182,184 (see 
Table 3.4). 
 
3.4 Outcomes  
This section describes the results of the primary and secondary outcomes.  Where 
possible, meta-analysis was performed, and logistic regression, M-H and POR odds 
ratios and 95% confidence intervals have been displayed together to aid visual 
inspection. 
Not all of the included studies provided data for every outcome predetermined by 
this review.  A summary of the data that were available in the included studies can 
be found below (see Tables 3.5 and 3.6).  Pain and analgesia requirements were not 
reported in any of the included trials or studies; all other outcomes were at least 
partially reported in the included studies.  Full statistical analysis and figures (forest 
plots) of the sensitivity analyses of statistical models (see Section 2.3.5) that are 
referred to throughout this section, individual study odds ratios and group numbers 
are presented in Appendix 7 for reference.  The trial by Enderson et al.63 contributes 
a large amount of data in a number of outcomes, with a significantly higher 
incidence than the other RCTs.  As a result, where possible, the influence of this 
study was tested through sensitivity analyses.  The results of these are presented 
throughout this section, where applicable, and in Appendix 7. 
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Table 3.5: Summary of primary outcome data available in the included studies  
PTX – pneumothorax; ICC – intercostal catheter; Yes – data available for both groups; No – no data available (shaded area); Partial – data available in conservative management group only (diagonal line shading)  
 
 
PTX – pneumothorax; LoS – length of stay; ICC – intercostal catheter; MV – mechanical ventilation; ICU – intensive care unit; Yes – data available for both groups; No – no data available (shaded area); Partial – 
data available in conservative management group only (diagonal line shading) 
 RCTs Cohort studies 























Progression of PTX Yes Yes Yes Yes Yes Partial Yes Yes Yes Yes Partial Partial 
Tension PTX Yes Yes Yes Yes Yes Partial Yes Yes Yes Yes Yes Yes 
Incidence of pneumonia/empyema No No Yes No Yes Partial No Yes Yes No No Partial 
ICC insertion (any reason) No Yes Yes Yes Yes Partial Yes Yes Yes Yes Partial Partial 
 RCTs Cohort studies 























ICC insertion (tension PTX) Yes Yes Yes Yes Yes Partial Yes Yes Yes Yes Yes Yes 
ICC insertion (progression to 
simple PTX) Yes Yes Yes Yes Yes Partial Yes Yes Yes Yes Partial Partial 
ICC insertion (non-PTX reason) No Yes Yes Yes Yes Partial Yes Yes Yes Yes Partial Partial 
Mortality No No Yes No Yes Partial No Yes Yes No No No 
Haemodynamic instability No No No No No No No No Yes No No No 
ICC complications Yes Partial Yes Yes Yes Partial No Yes Yes No No Yes 
ICU LoS No No Yes No Yes Partial No No Yes No No No 
Hospital LoS No No Yes No Yes Partial No No Yes No No No 
MV duration Yes No Yes No No Partial Yes No No No No No 
Duration of ICC dwelling No No Yes No Yes No No No No No No No 
Pain and analgesia requirement No No No No No No No No No No No No 
Table 3. 6 : Summary of secondary outcome data available in the included studies 
Legend (for table 3.5 and 3.6) 
 No data available  
 Data available in conservative Mx group only  
 
Page 67 of 146 
 
3.4.1 Primary outcomes  
3.4.1.1 Progression of pneumothorax  
Incidence of progression of pneumothorax was reported in all included studies for 
the conservative management group (see Table 3.5).  Three cohort studies10,167,184 
did not report progression of pneumothorax in the ICC ventilated patient group (see 
Table 3.5).  The rate of progression of pneumothorax within the RCTs in the 
conservative management group was 15.1% (14 out of 93) compared with 9.8% (six 
out of 61) in the ICC group.  Enderson et al.63 reported eight cases in the 
conservative management group, making up more than half (eight out of 14) of the 
reported cases.  Meta-analysis using a mixed-methods logistic regression model 
showed no statistical difference between the groups, but suggested that patients 
managed with initial ICC insertion had 2.36 times decreased odds of pneumothorax 
progression (95% CI 0.81-6.8; see Figure 3.2).  Similar relative effects were found 
from the sensitivity analyses with other statistical models (see Figure 3.2, Appendix 
7: Figures 7.1 and 7.2).  Sensitivity analyses performed to explore the influence of 
the study by Enderson et al.63 showed a logistic regression odds ratio of 0.85 (95% 
CI 0.25-2.94) and a M-H odds ratio of 0.86 (95% CI 0.25-2.99, see Appendix 7: 
Figure 7.3).  In both analyses, the effect estimate changed in favour of conservative 
management, and a reduced relative difference between groups, with 15% decreased 
odds. 
 
Principal analysis of three RCTs using mixed effect logistic regression. Other analyses presented are available in Appendix 7 
(see Figures 7.1 and 7.2).  
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, RE – random effects, POR – Peto odds ratio, OR – odds 
ratio 
Figure 3.2: Progression of pneumothorax – randomised controlled trials 
In the cohort studies, there were three out of 66 (4.5%) in the conservative 
management group and two out of 55 (3.6%) in the ICC group.  The meta-analysis 
for cohort studies showed similar results to those of the RCTs (logistic regression 
odds ratio = 2.58, 95% CI 0.39-17.09), albeit with less precision (wider confidence 
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intervals) and greater disparity between the different statistical models in the 
sensitivity analyses (see Figure 3.3, Appendix 7: Figures 7.4 and 7.5).  
 
Principal analysis of six cohort studies using mixed effect logistic regression. Other analyses presented are available in 
Appendix 7 (see Figures 7.4 and 7.5).  
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, FE – fixed effects, POR – Peto odds ratio, OR – odds 
ratio 
Figure 3.3: Progression of pneumothorax – cohort studies 
3.4.1.2 Intercostal catheter insertion (any reason) 
ICC insertion (for any reason) was reported in all but one study179 in the ventilated 
conservative management group.  In the ventilated ICC group, four 
studies10,167,179,184 did not report the incidence of ICC insertion (for any reason) (see 
Table 3.5).  A breakdown of the reasons for ICC insertion is presented in Table 3.7.  
Further description and analysis of the ICC insertion reasons are presented in 
Sections 3.4.2.2 to 3.4.2.4. 
Table 3.7: Breakdown of intercostal catheter insertion reasons 
ICC insertion reason Conservative Mx group ICC group 
Any reason 24/150 (16%) 13/107 (12.1%) 
Tension PTX 4/159 (2.5%) 1/116 (0.8%) 
Progression to simple PTX 13/159 (8.2%) 3/116 (2.5%) 
Progression of PTX 
(i.e. simple + tension) 
17/159 (10.6%) 4/116 (3.4%) 
Non-PTX reason 9/150 (6%) 9/107 (8.4%) 
ICC – intercostal catheter; Mx – management; PTX – pneumothorax 
 
In the RCTs, there were 18 out of 84 (21.4%) in the conservative management group 
and in the ICC group there were eight out of 52 (15.4%).  Meta-analysis showed that 
the ICC group had 4.2 times decreased odds of having an ICC inserted (95% CI 
0.33-52.5).  There is however low certainty in these findings due to noticeable 
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imprecision evidenced by the large range of confidence intervals in the logistic 
regression model and in the M-H sensitivity analysis (see Figure 3.4, Appendix 7: 
Figures 7.6 and 7.7).  The effect size is also skewed by Enderson et al.63 due to the 
high incidence of ICC insertion in the conservative management group.  Removing 
Enderson et al.63 to assess its affect leaves data from one RCT65, with a calculated 
odds ratio of 1.00 (95% CI 0.35-2.8). 
 
Principal analysis of two randomised controlled trials using mixed effect logistic regression. Other analyses presented are 
available in Appendix 7 (see Figures 7.6 and 7.7). 
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, RE – random effects, POR – Peto odds ratio, OR – odds 
ratio 
Figure 3.4: Intercostal catheter insertion (any reason) – randomised controlled trials 
In the cohort studies, there were six out of 66 (9.1%) in the conservative 
management group with the same rate (9.1%, five out of 55) in the ICC group.   
Meta-analytical modelling showed different results to the RCTs, although this was 
very consistent across the three models used, with an odds ratio of 1.78 (95% CI 
0.45 – 7.04).  This was also shown also in the sensitivity analyses (see Figure 3.5, 
Appendix 7: Figures 7.8 and 7.9). 
 
Principal analysis of six cohort studies using mixed effect logistic regression. Other analyses presented are available in 
Appendix 7 (see Figures 7.8 and 7.9). 
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, FE – fixed effects, POR – Peto odds ratio, OR – odds 
ratio 
Figure 3.5: Intercostal catheter insertion (any reason) – cohort studies 
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3.4.1.3 Incidence of pneumonia/empyema  
Data for incidence of pneumonia/empyema were available from one RCT65, with 
calculated odds ratio suggested a non-significant 66% decreased chance of 
developing pneumonia/empyema (OR 1.66, 95% CI 0.59 – 4.65) for the ICC group. 
 
In contrast to the results for RCTs presented in Figure 3.6, meta-analysis of cohort 
studies showed a decreased odds ratio for the incidence of pneumonia and empyema 
for the conservative management group (odds ratio = 0.7, 95%CI 0.19 – 2.5; see 
Figure 3.7).  Sensitivity analyses showed similar results (see Figure 3.6, Appendix 7: 
Figures 7.10 and 7.11).    
 
Principal analysis of three cohort studies using mixed effect logistic regression. Other analyses presented are available in 
Appendix 7 (see Figures 7.10 and 7.11). 
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, FE – fixed effects, POR – Peto odds ratio, OR – odds 
ratio 
Figure 3.6: Pneumonia/empyema incidence – cohort studies 
3.4.1.4 Incidence of tension pneumothorax 
The incidence of tension pneumothorax was low in both the conservative 
management and ICC groups. Four instances were reported (four out of 159; 2.5%) 
in the conservative management group, all in the RCTs.63,65 Enderson et al.63 
reported the highest incidence, with three cases in their conservative management 
group.   There was one incidence in 152 cases (0.7%) reported in the ICC group, 
which was reported in a cohort study.182   
 
3.4.2 Secondary outcomes  
3.4.2.1 Mortality (all-cause)  
One experimental study65 reported data for mortality.  Four patients in each group 
died.  Calculation of the odds ratio for this study confirmed a non-statistically 
Page 71 of 146 
 
significant decrease in mortality in the conservative management group (odds ratio 
0.78, 95% CI 0.18-3.34). 
Across the included cohort studies, there was a higher observed incidence (12 out of 
40) of mortality in the ICC group compared to the conservative management group 
(four out of 50).  Logistic regression produced an odds ratio of 0.36 (95% CI 0.1-
1.27) confirmed by analyses using alternative methods (see Figure 3.7, Appendix 7: 
Figures 7.12 and 7.13). 
 
Principal analysis of three cohort studies using mixed effect logistic regression. Other analyses presented are available in 
Appendix 7 (see Figures 7.12 and 7.13) 
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, FE – fixed effects, POR – Peto odds ratio, OR – odds 
ratio 
Figure 3.7: Mortality (all-cause) – cohort studies 
3.4.2.2 Intercostal catheter insertion (tension pneumothorax)  
All five tension pneumothoraces recorded in the included studies required ICC 
insertion (see Section 3.4.1.3).  There were four in the conservative management 
group and one in the ICC group. 
 
3.4.2.3 Intercostal catheter insertion (progression to simple pneumothorax)  
A statistically significant difference was seen in the logistic regression analysis with 
patients in the ICC group having 4.8 times less chance of receiving an ICC for 
progression to a simple pneumothorax (95% CI 1.01 – 23.6).  Calculated effect 
estimates from sensitivity analyses with other statistical models varied (see Figure 
3.8, Appendix 7: Figures 7.14 and 7.15), likely due to the number of zero events and 
use of continuity correction in the M-H model in the ICC group in two of the 
RCTs.63,179  Sensitivity analyses performed exploring the effect of the study by 
Enderson et al.63 showed a decreased odds ratio and loss of statistical significance, 
however this was still in favour of the ICC group (logistic regression odds ratio 2.25, 
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95% CI 0.4 – 12.3 and a M-H odds ratio of 1.83, 95%CI  0.37 – 9.02) (see Appendix 
7: Figure 7.16).  
 
Principal analysis of three RCTs using mixed effect logistic regression. Other analyses presented are available in Appendix 7 
(see Figures 7.14 and 7.15). 
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, RE – random effects, POR – Peto odds ratio, OR – odds 
ratio  
Figure 3.8: Intercostal catheter insertion (progression to simple pneumothorax) – 
randomised controlled trials 
Meta-analyses of the cohort studies revealed similar results to those of the RCTs, 
with 3.7 times decreased odds of receiving an ICC for progression to a simple 
pneumothorax (95% CI 0.29 – 47.8).  The effect was not statistically significant and 
showed greater imprecision than the analysis of experimental studies (see Figure 
3.9).  The use of continuity correction in the M-H model is again seen to have an 
effect in reducing the effect estimate compared to the other statistical models (see 
Figure 3.9, Appendix 7: Figures 7.17 and 7.18). 
 
Principal analysis of six cohort studies using mixed effect logistic regression. Other analyses presented are available in 
Appendix 7 (see Figures 7.17 and 7.18). 
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, FE – fixed effects, POR – Peto odds ratio, OR – odds 
ratio 
Figure 3.9: Intercostal catheter insertion (progression to simple pneumothorax) – cohort 
studies 
3.4.2.4 Intercostal catheter insertion (non-pneumothorax reason) 
Meta-analysis using logistic regression suggests a 23% decreased chance of 
receiving an ICC for non-pneumothorax reasons in the conservative management 
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group (OR 0.77, 95% CI 0.2 – 2.6).  Due to double arm zero event results in one 
study63, two stage meta-analytical models (M-H/Peto) could not be utilised.  
Therefore, sensitivity analyses with these models were not undertaken for the RCTs 
for this outcome. 
 
Logistic regression for the cohort studies suggested increased odds of receiving an 
ICC for non-pneumothorax reasons in the conservative management group, with an 
odds ratio of 1.72 (95% CI 0.31 – 9.5; see Figure 3.11).  This was again replicated in 
the sensitivity analyses (see Figure 3.10, Appendix 7: Figures 7.19 and 7.20).  
However, the incidence was lower in the conservative management group (3.5% 
versus 5.5%).  The disparity between the analyses and incidence is likely due to 
three studies10,167,184 that were not included in the meta-analysis as they only had 
data for the conservative management group.  In these three studies10,167,184, there 
was no reported incidence of ICC insertion for non-pneumothorax reasons. 
 
 
Principal analysis of six cohort studies using mixed effect logistic regression. Other analyses presented are available in 
Appendix 7 (see Figures 7.19 and 7.20). 
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, FE – fixed effects, POR – Peto odds ratio, OR – odds 
ratio 
Figure 3.10: Intercostal catheter insertion (non-pneumothorax reason) – cohort studies 
3.4.2.5 Hospital length of stay 
One RCT65 reported the following hospital length of stay (median and interquartile 
range [IQR]): 18.0 days (10.0-47.0) for the conservative management group, and 
16.0 days (8.5-42.0)  for the ICC group.  Three cohort studies167,169,182 reported on 
this outcome; results are displayed in Table 3.8.  Hospital length of stay was reduced 
in the conservative management group. 
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Intercostal catheter group 
Collins et al.169 
13 (1-32) days 
Mean (range) 
18.8 (6-36) days 
Mean (range) 
Fulton & Bratu167 
17.8 (3-79) days 
Mean (range) 
 
Llaquet Bayo et al.182 
17.2 (8.3-27.9) days 
Median (IQR) 
19.5 (6.4-28.4) days 
Median (IQR) 
IQR - interquartile range 
 
3.4.2.6 Intensive care unit length of stay 
One RCT65 reported the following ICU length of stay (median and IQR): 5.0 (2.0-
11.5) days for the conservative management group, and 4.0 (1.0-9.5) days for the 
ICC group.  The outcomes from three cohort studies167,169,182 are displayed in Table 
3.9.  The data from the cohort studies suggest that the conservative management 
group had a shorter ICU length of stay, and the difference between groups appeared 
more pronounced than the difference in hospital length of stay (see Table 3.8). 




Intercostal catheter group 
Collins et al.169 
4.14 (0-12) days 
Mean (range) 
13.6 (2-30) days 
Mean (range) 
Fulton & Bratu167 
4.4 (1-14) days 
Mean (range) 
 
Llaquet Bayo et al.182 
8.4 (7-20.3) days 
Median (IQR) 
16.1 (6.7-22.8) days 
Median (IQR) 
IQR - interquartile range 
 
3.4.2.7 Duration of mechanical ventilation  
Duration of mechanical ventilation was recorded in two RCTs65,179 and two cohort 
studies.167,181  RCT results are displayed in Table 3.10.  There were minimal 
differences between the two groups.  The cohort studies were both paediatric studies 
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and only reported mechanical ventilation duration in the conservative management 
group.  Fulton & Bratu167 had a mean of 2.3 days and range of 0 to 13.  Holmes et 
al.181 had two patients; one received mechanical ventilation for two hours and the 
second patient for 16 days. 





Intercostal catheter group 
Brasel et al.179 
1 (1-19) days 
Median (range) 
2 (1-4) days 
Median (range) 
Kirkpatrick et al.65 
3.0 (0-8.0) days 
Median (IQR) 
2.5 (0-6.5) days 
Median (IQR) 
IQR - interquartile range 
 
3.4.2.8 Duration of intercostal catheter dwelling  
Duration of ICC dwelling was recorded in one RCT65 and one cohort study.169  This 
was only reported in the ICC group.  Kirkpatrick et al.65 reported a median and 
interquartile range of 5.0 (4.0-8.0) days.  Collins et al.169 had a mean and range of 
6.33 (2-20) days and a median of three days. 
3.4.2.9 Haemodynamic instability  
None of the RCTs reported data on haemodynamic instability.  One cohort study182 
reported on haemodynamic instability, which was defined as systolic blood pressure 
less than 90mmHg or heart rate greater than 100 beats per minute.  Haemodynamic 
instability was reported in nine out of 16 (56%) patients in the conservative 
management group and 14 out of 26 (54%) patients in the ICC group; there was no 
difference between the two groups. 
3.4.2.10 Pain and analgesia requirements 
None of the included studies reported any data on pain or analgesia requirements.  
3.4.3 Intercostal catheter complications 
ICC complications were reported in the majority of studies10,16,63,65,169,170,179,182 
(8/12).  The overall rate of ICC complication in both groups was 21% (31 out of 
147). 
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3.4.3.1 Intercostal catheter complication (composite) 
In the RCTs, there were 11 out of 49 (22%) ICC complications in the ICC group, 
and one out of 20 (5%) in the conservative management group when an ICC was 
required to be inserted.  Meta-analysis for this outcome using logistic regression or 
M-H models could not be performed.  The logistic regression model could not be 
performed due to no events being reported in the conservative management group 
and the M-H model could not be performed due to double arm zero event in one 
study.179  Data from Kirkpatrick et al.65 gives a calculated M-H odds ratio of 0.12 
(95% CI 0.01 – 2.26), which was not statistically significant. 
 
In the analysis of cohort studies, the continuity correction used in the M-H model 
had a marked effect on the calculated effect estimate (see Figure 3.11, Appendix 7: 
Figures 7.21 and 7.22).  This is likely due to the small numbers of patients (six) in 
the conservative management group requiring placement of an ICC and no 
complications occurring in this group.  A total of 11 complications out of 60 ICCs 
placed (18.3%) were reported in the ICC groups in the included cohort studies. 
 
Principal analysis of five cohort studies using mixed effect logistic regression. Other analyses presented are available in 
Appendix 7 (see Figures 7.21 and 7.22). 
CI – confidence interval, ME – mixed effects, M-H – Mantel-Haenszel, FE – fixed effects, POR – Peto odds ratio, OR – odds 
ratio  
* due to zero events in all studies in conservative management group,  a logistic regression model could not be used 
Figure 3.11: Intercostal catheter complications – cohort studies 
3.4.3.2 Intercostal catheter complication (breakdown) 
ICC complications were divided into malpositioning, infection, organ injury and 
vascular injury.  A summary of the breakdown is presented in Table 3.11 and a 
further description follows below. 
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Table 3.11: Intercostal catheter Complications Breakdown for All Included Studies 
 Conservative management 
group 
(26 ICC inserted and complications 
documented) 
Intercostal catheter group 
(109 had complications documented) 
Composite 1 (3.8%) 22 (20%) 
Malpositioning 0 13 (10.7%) 
Infection 1 (3.8%) 3 (2.8%) 
Organ injury 0 0 
Vascular injury 0 2 (1.6%) 
Other/unspecified 0 4 (3.3%) * 
*Other/unspecified   
- Collins et al.169: patient self- removed intercostal catheter, requiring replacement 
 - Kilpatrick et al.65: patient self-removed intercostal catheter, requiring replacement 
 - Lee et al.16: persistent intercostal neuralgia 
 - Zhang et al.10: unspecified  
 
Kirkpatrick et al.65 reported ten malpositioning complications, all in the ICC group, 
with eight of these requiring replacement ICCs.  In the cohort studies, there were 
three malpositioning complications, two in Llaquet Bayo et al.182 and one in Ball et 
al.170, with all three requiring replacement ICCs. 
Enderson et al.63 reported one infective complication in the conservative 
management group, where a patient who required an ICC placement for progression 
of pneumothorax developed an empyema.   
Lee et al.16 reported three infective complications in the ICC group.  One patient 
developed an empyema and two patients developed a local wound infection.  In this 
study, it was not possible to compare ICC management against conservative 
management as there were no requirements for ICC placement in the conservative 
management group. 
There were two vascular injuries in the included studies, both reported in Ball et 
al.170 in the ICC group. There were no organ injuries reported in any of the included 
studies. 
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Chapter 4: Discussion  
This chapter discusses the results of the systematic review presented in the previous 
chapter, its limitations, and the implications for practice and future research. 
 
4.1 Results in context  
Conservative management can be considered a safe alternative to ICC insertion for 
the initial management of occult pneumothoraces in mechanically ventilated 
patients.  The results of the systematic review of available evidence presented in this 
thesis show that conservative management and ICC insertion are both equally 
effective.  Considering the nature of the evidence and results presented, including 
the small sample size included and imprecision in many of the results reported, this 
remains an uncertain result.  Despite this, given the non-invasive nature of 
conservative management, the low incidence of tension pneumothorax and the 
highly monitored environment in which mechanically ventilated patients are cared 
for, the evidence suggests conservative management may be favoured over ICC 
insertion, considering the evident harms associated with ICC insertion. 
 
Considering the effectiveness of the two management strategies, ICC insertion for 
progression to simple pneumothorax was the only outcome that showed a benefit for 
ICC insertion.  Despite relatively equal effectiveness being shown in the other 
measures, the evidence did suggest the risk was reduced in the ICC group for 
progression of pneumothorax, ICC insertion for any reason and incidence of 
pneumonia/empyema.  However, the risk of mortality and ICC insertion for non-
pneumothorax reason was reduced in the conservative management group.  
Interestingly, there was a higher risk of receiving an ICC for progression of 
pneumothorax in the conservative management group despite no difference being 
shown in the outcome of progression of pneumothorax.  This is likely due to a 
proportion of the pneumothoraces that progressed in the ICC group having been 
managed without the insertion of another ICC.  The pneumothoraces, in some cases, 
could be resolved by placing the ICC on suction (see Section 1.4.2). 
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The outcomes of progression of pneumothorax, ICC insertion for any reason and 
ICC insertion for progression to simple pneumothorax in the RCT analysis were 
heavily skewed in favour of the ICC group by the study by Enderson et al.63, which 
had a much higher incidence of progression of pneumothorax than the other two 
RCTs.65,179  The reason for this higher incidence is unclear from the information 
provided, however it can be speculated that the common ventilator settings of the 
time may have contributed to it (see Section 1.5.2).  Prior to the ARDSnet (Acute 
Respiratory Distress Syndrome Network) article122 published in 2000, it was 
common for tidal volumes to be set at 10-12ml/kg.  Since this study was conducted, 
it has been recognised that there are better outcomes in all patient groups when 
lower tidal volumes are used126,127, with 6-8ml/kg ideal body weight now routinely 
being used.124,125  The use of these lower tidal volumes requires lower pressures to 
be applied to the lungs by the ventilator and as the pressure gradient is what is 
believed to cause progression of pneumothorax and development of tension 
pneumothoraces; lower pressures will likely lead to a lower incidence of both (see 
Section 1.2.1).  Unfortunately, tidal volumes were not reported in the study by 
Enderson et al..63  Sensitivity analyses performed to explore the influence of the 
study by Enderson et al.63 suggested that the risk of progression of pneumothorax 
was lower in the conservative management group, and ICC insertion for progression 
to simple pneumothorax lost statistical significance. 
The length of time that a patient is ventilated may also increase the risk of 
progression of pneumothorax, however most studies did not investigate this link.  
Through subgroup analysis, Kirkpatrick et al.65 found that there was a trend toward a 
higher incidence of progression of pneumothorax when patients required sustained 
mechanical ventilation; the risk increased threefold after seven days. 
 
For some outcomes, there were noticeable differences between effect estimates from 
RCTs and cohort studies; these included contradictory results in the incidence of 
pneumonia/empyema, and significant decreased risk of mortality and decreased 
length of stay in both hospital and ICU in the conservative management group in the 
cohort studies.  This may be due to differences in how confounding factors were 
handled between study designs.  It is unclear what the exact confounding factors 
were, however it is likely that in the cohort studies, more severely injured patients 
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would be preferentially chosen to receive an ICC if they had an occult 
pneumothorax.  This would then explain the higher mortality, higher incidence of 
pneumonia/empyema and longer time in both ICU and hospital for the ICC group in 
the cohort studies.  The only objective evidence to support the acuity of included 
patients was the injury severity score (ISS), however there was no significant 
difference in the baseline characteristics of the cohort studies (see Table 3.3).  
   
In regards to the safety of the two management strategies, the major concerns with 
conservative management are progression of pneumothorax, tension pneumothorax 
and need for ICC insertion.  The incidence of progression of pneumothorax was 
15.1% in RCTs and 4.5% in cohort studies.  The incidence of tension pneumothorax 
in this series was 2.5%, with three out of the four reported in one RCT.63  If we 
disregard this study, the incidence becomes 0.7%.  There was also a tension 
pneumothorax reported in the ICC group.  It occurred in ICU 48 hours after the 
initial ICC was inserted and required another ICC to be inserted.182  It is important to 
note that the insertion of an ICC does not completely negate the risk of tension 
pneumothorax.  Investigating the requirement for an ICC insertion for any reason in 
the conservative management group in this research showed almost 80% of patients 
in the RCTs did not require the invasive procedure of an ICC insertion.  As this 
procedure is invasive, it comes with a set of risks and potential complications, 
including malpositioning (and failure of drainage), infection and damage to internal 
structures (see Section 1.4.3).  This is the safety concern with ICC insertion.  The 
total incidence of ICC complications in this series was 17% (20% in the ICC group), 
in keeping with previously published literature, with a reported incidence of 20-
35%.66,85-89  The incidence was significantly higher in the ICC group; possible 
explanations for this include suboptimal conditions in urgent ICC insertion and 
easier insertion following pneumothorax progression.  ICCs placed initially in 
trauma patients are often inserted in suboptimal conditions due to reduced access to 
the patient, with other procedures occurring and less attention paid to ensuring 
adequate sterile conditions and optimal positioning due to time pressure.  When an 
ICC is inserted for progression of pneumothorax or haemothorax in patients 
managed with conservative management, there is often time to ensure optimal 
conditions and positioning are used (except in the case of a tension pneumothorax).  
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In the case of insertion of an ICC for pneumothorax, it will be easy after it has 
progressed as there will be more space within the pleural cavity.  This should make 
placement of a large-bore ICC easier and will also allow for insertion of a pigtail 
drain via the Seldinger technique. 
Pigtail drains are becoming popular as it is a less invasive procedure than the blunt 
dissection technique required for a large-bore ICC (see Section 1.4.1.3).  A RCT78 
reported significantly lower pain scores in patients who received a pigtail drain 
versus a large-bore ICC on the day of insertion and over the days after insertion.  
The same author also investigated the effectiveness of pigtail catheters for drainage 
of pneumothoraces, with comparable efficacy to wide bore ICCs.185 A meta-
analysis186 investigating pigtail catheters for all causes of pneumothoraces showed a 
similar management success rate and a lower complication rate, however within the 
traumatic subgroup, both the success rate and complication rate were the same for 
each technique.  Similar findings were found in a meta-analysis187 investigating the 
use of pigtail catheters for management of traumatic pneumothoraces and 
haemothoraces, with a success rate of 90-100%.  Unfortunately, none of the studies 
in this series reported which method was used for insertion of ICCs in the 
conservative management group.  However, it would be interesting to ascertain 
whether the use of a pigtail catheters for progression of pneumothorax improves 
outcomes. 
Compared to the previous ‘mini-reviews’1,2, this review had a higher number of 
patients within the RCTs and cohort studies, and a higher number of outcomes were 
investigated.  This provides a more complete picture of the benefits, harms and 
adverse effects of both management strategies.  The results of this review are in 
keeping with the findings of previous ‘mini-reviews’, however the more explicit 
methods used, and the larger evidence pool increase the certainty in the findings.  
Nevertheless, there remains the need for further large multi-centre RCTs to fully 
address this question as the evidence is still limited in this review.  The full analysis 
of the OPTICC study168 will add additional information to this query.   
 
Overall, from the limited evidence found in this systematic review, conservative 
management and ICC insertion was shown to be equally effective for the 
management of occult pneumothoraces in mechanically ventilated patients.  
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Conservative management can be considered a safe method of managing occult 
pneumothoraces in mechanically ventilated patients, with the caveat that patients are 
in a highly monitored environment, caregivers are aware the patient has an occult 
pneumothorax and there is appropriate staff readily available to recognise and treat a 
tension pneumothorax.  The lower rate of ICC complications in the 20% of patients 
that required a subsequent ICC insertion further adds to this safety.   
 
4.2 Limitations of included studies  
The limitations of the studies identified and included in this systematic review 
appear to fall under three main categories: rare events, small studies and inability to 
find/access raw data. 
The majority of predefined outcomes presented in this systematic review had low 
incidence; this was especially the case in observational studies.  Due to the low 
incidence and often small study size, there was a high proportion of zero event arms 
in the included studies.  Some studies had double arm zero events (i.e. no events 
recorded in either group).  This made meta-analysis difficult (see Section 2.3.5) and, 
in some outcomes, conducting a meta-analysis was not feasible at all.  Despite single 
and double arm zero event studies not always being able to be included in meta-
analysis, they did add weight to the rarity of some outcomes in this systematic 
review and provided additional important data to help ascertain the safety of the two 
management strategies. 
Unfortunately, there is likely to be available data that were not included in this 
systematic review due to the inability to access it.  All but two65,167 of the included 
studies had ventilated patients as a subset of the total study and they often did not 
report the outcomes for ventilated patients separately, hence these data were lost to 
this systematic review.  Some data were clarified with the authors, however many of 
the studies were from more than ten years ago and the data are no longer available, 
and some authors did not respond to correspondence.  In addition, two cohort 
studies10,184 did not report most of the data for the ICC group, especially for the 
ventilated subgroup.  Due to this, data from these two studies could not be included 
in any meta-analyses. 
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4.3 Limitations of systematic review 
The limitations inherent to this systematic review include small sample sizes, sparse 
data and parts of the review being completed by a single reviewer only.  Due to the 
small sample size in the RCTs available on this topic and observational data being 
essential to gaining a picture of adverse events, an a priori decision was made to 
include cohort studies (prospective and retrospective).146  In addition to the small 
sample size, there was sparsity of data, which led to high imprecision (wide 
confidence intervals) for the majority of outcomes.  Due to this, there is a low 
certainty of the findings from this review. 
The screening process was, in most parts, performed by one reviewer.  The 
screening of titles, abstracts and full texts was performed by a single reviewer, 
except in the case where it was deemed unclear whether an article should be 
included or not.  The use of a single reviewer may have resulted in overlooking and 
missing relevant articles.  To minimise this, the title and abstracts were screened 
twice, and a hand search of the included study reference lists occurred.  Data 
extraction was also performed by a single reviewer which may have led to data 
handling errors.  Care was taken to ensure accurate data extraction and data were 
crossed checked with the articles, once extracted. 
 
4.4 Implications for practice  
The main implications of the results of this systematic review are that the best 
available evidence suggests that conservative management can be considered a safe 
management strategy for occult pneumothoraces in mechanically ventilated patients, 
and that ICC complications are common.  When conservative management was used 
in the RCTs in this series, nearly 80% of patients did not require an ICC to be 
inserted for any reason, meaning four out of five patients were successfully managed 
without the need for an invasive procedure.  When an invasive procedure was 
required, almost one in five patients had an ICC complication, with many of these 
requiring insertion of another ICC.  Importantly, inserting an ICC did not necessarily 
stop a pneumothorax from progressing and a tension pneumothorax could still have 
occurred. 
 
Page 84 of 146 
 
4.5 Implications for future research  
Two of the included RCTs65,179 used respiratory distress as their primary outcome.  
This was not included as an outcome in this systematic review due to the subjective 
nature of respiratory distress, the lack of definition from one RCT179 and a long list 
of possibilities from the second65, many of which could have been confounded by 
other factors.  Consistent use of the same, important, objective outcomes would have 
aided interpretation and synthesis.  This could be aided by the use of a core set of 
outcomes through the COMET (Core Outcome Measures in Effectiveness Trials) 
initiative, which aims to develop and encourage application of an agreed 
standardised set of outcomes to be reported in clinical trials.188  There is currently no 
core outcome set for investigating the management of pneumothoraces.189  
There is scope to include patient centred outcomes, such as pain, in future RCTs, 
using validated tools for measuring pain in mechanically ventilated and sedated 
patients151,152 or by the surrogate of analgesia requirements.  Both pain and opiate 
use has been shown to be a risk factor for ICU delirium, especially in the older 
population, which can increase duration of ventilation and ICU length of stay.190,191 
A related focus that could be of interest would be to investigate the use of the 
Seldinger technique pigtail drain versus a larger bore ICC for patients managed 
conservatively that require an ICC insertion for progression of pneumothorax.  
Pigtail drains have been shown to produce less pain than a larger bore ICC78 and 
they leave a smaller scar.  If pigtail drains are shown to be non-inferior, they could 
be used more readily in this situation.  
 
4.6 Conclusions 
More evidence is required to fully inform the effectiveness of conservative 
management for occult pneumothoraces in mechanically ventilated patients.  
However, the evidence we have to date suggests that conservative management is a 
safe method for the management of occult pneumothoraces in mechanically 
ventilated patients, provided that the patients are in a highly monitored environment, 
the caregivers are aware that the patient has an occult pneumothorax and that there is 
appropriate staff available to recognise and treat tension pneumothorax if it occurs.  
To promote consistency in practice, clear guidelines should be created, aligning 
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which patients can be conservatively managed and how progression of 
pneumothorax is to be monitored.  
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Appendices 
Appendix 1: Systematic review protocol 
Wolters Kluwer permits use of the final peer-reviewed manuscript of this Protocol in print thesis. 
Effectiveness and Safety of Conservative Management for 
Occult Pneumothorax in Mechanically Ventilated Patients: 
A Systematic Review Protocol 
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Abstract  
Objective: This systematic review aims to synthesise available evidence 
investigating the effectiveness and safety of conservative management for occult 
pneumothorax in mechanically ventilated patients. 
Introduction: Occult pneumothorax is air within the pleural cavity that is diagnosed 
on a CT scan but was not suspected on the basis of preceding clinical examination or 
supine chest x-ray.  Its incidence has increased with the increased use of CT scans 
for trauma.  Currently, there is no consensus on how to manage these, especially in 
patients requiring mechanical ventilation.  Common practice is to place a 
prophylactic intercostal catheter (ICC) to stop the potential development of a tension 
pneumothorax, this however brings with it a 20% risk of major complications from 
the ICC insertion.  Recent evidence may suggest that occult pneumothorax in 
mechanically ventilated patients can be managed with conservatively, rather than 
using a prophylactic ICC as first-line management. 
Inclusion Criteria: This review will include studies investigating stable patients of all 
ages, diagnosed with a traumatic occult pneumothorax on a CT scan that receive 
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mechanical ventilation, who were managed with conservative management or ICC 
insertion. 
Methods: Eligible studies will include randomized and non-randomized controlled 
trials, and prospective and retrospective cohort studies.  PubMed, EMBASE, 
CINAHL, Web of Science and Cochrane Central Register of Controlled Trials will 
be searched. International clinical trials registry (ICTR), Australian and New 
Zealand clinical trials registry (ANZCTR) and Clinicaltrials.gov will be searched for 
unpublished studies.  All included studies will be critically appraised using 
standardised JBI tools, with no exclusions based on methodological quality. Studies 
will, where possible, be pooled in statistical meta-analysis, with impact of 
methodological quality to be explored with sensitivity analysis. 
 
Review question 
What is the effectiveness and safety of conservative management of occult 
pneumothorax in mechanically ventilated patients?  
 
Introduction 
Occult pneumothorax was first described in 1983-84,1,2 after pneumothoraces were 
seen on lung windows from abdominal and head computed tomography (CT scans) 
that hadn’t previously been identified on chest x-rays.  The definition of occult 
pneumothorax has since been refined to air within the pleural cavity that is 
diagnosed on CT scan but was not suspected on the basis of preceding clinical 
examination or supine chest x-ray.3-5  The overall incidence in trauma patients is 
approximately 5%,3,4 although an incidence as high as 37% has been reported in 
some studies.6-8  
Although occult pneumothorax was first described over 30 years ago, there is no 
consensus on its best management strategy for occult pneumothorax; this is 
especially the case with patients receiving mechanical ventilation.  The Advanced 
Trauma Life Support (ATLS) Manual,9 the primary source globally for medical 
education on trauma management, recommends that all patients diagnosed with a 
pneumothorax that receive mechanical ventilation require placement of an 
intercostal catheter (ICC). The Emergency Trauma Management (ETM) Course 
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Manual,10 a recently formed critical care-focused trauma course, is less prescriptive.  
It states that although classical teaching is to place an ICC for a pneumothorax in a 
patient undergoing mechanical ventilation, this has been challenged recently and 
observation may be appropriate.  A survey completed in the UK showed there is 
disagreement between medical specialties that commonly manage this group of 
patients, with variation from 28% to 100% that would place a prophylactic ICC.11  
The concern with occult pneumothorax in patients receiving mechanical ventilation 
is the potential risk of progression to a tension pneumothorax, which can be life- 
threatening.   Due to the risk of this life-threatening sequela, prophylactic insertion 
of an ICC is common.  Unfortunately, ICC insertion is not without risk and is 
associated with a major complication rate of up to 20%.12,13    Complications include 
cardiac and vascular injury, intraparenchymal lung injuries, solid organ injuries 
(including liver and spleen), malpositioning (requiring reinsertion) and infection 
(empyema and wound infection).  These complications do not include the pain 
involved in both insertion and dwelling, or the large scar that remains.  The risk of 
malpositioning means that ICC insertion does not ensure that the progression to 
tension pneumothorax can be prevented and may actually delay the diagnosis of 
tension pneumothorax if it does occur.  Patients may be exposed to a higher risk of 
harm, with the lack of consensus in both teaching of trauma management and 
between specialities managing these patients leading to a high probability of clinical 
practice variation. 
Inconsistent results reported in research studies investigating management of occult 
pneumothorax further highlight controversies in this field.  A study by Enderson et 
al14 included 40 patients with occult pneumothorax and randomized them to 
observation or ICC placement, of this, 27 received mechanical ventilation (15 in the 
observation group and 12 in the ICC group).  In the observation group, three 
developed tension pneumothorax and a further five patients had progression of 
pneumothorax requiring ICC placement.  From this study, it was advised that all 
patients with an occult pneumothorax who require mechanical ventilation receive a 
prophylactic ICC.  More recent studies have shown no tension pneumothoraces and 
no increased mortality with observation alone in mechanically ventilated patients.  
These studies have reported a “failure” of observation (defined as requirement for 
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ICC insertion) between 13-30%.5,15,16 Despite this apparent high failure rate, the 
corollary is that at least 70% of patients have avoided an unnecessary procedure.   
 
Similar mechanisms account for pneumothorax caused by blunt and penetrating 
trauma.  In blunt trauma, pneumothorax can occur via three mechanisms.17  First, 
direct injury to the pleura by fractured or dislocated ribs.  If no rib fractures are 
present, the suspected mechanism is either rupture of alveoli with the increased 
pressure caused by sudden chest compression or, uncommonly, increased pressure in 
the trachea or bronchi with a closed glottis causing rupture in the larger airways.  
The mechanism of pneumothorax in penetrating trauma is simpler and more direct, 
with air either entering the pleural cavity from a penetrating wound or direct damage 
to the lung.17 As a proportion of the blunt pneumothoraces are caused by a 
penetrating mechanism from fractured or dislocated ribs, blunt and penetrating 
trauma will be considered together in our review.  
A preliminary search of PROSPERO, PubMed, the Cochrane Database of 
Systematic Reviews and the JBI Database of Systematic Reviews and Implementation 
Reports failed to identify any recent or underway systematic reviews on the topic.  
One systematic review was identified on the topic of occult pneumothorax by Yadav 
et al in 2009.18  These authors investigated the safety of observing occult 
pneumothorax in all trauma patients, not only those patients receiving mechanical 
ventilation.  They included three RCTs, with variable results for and against the use 
of conservative management.  Since this review there has been more research 
conducted and published on occult pneumothorax in the patient population requiring 
mechanical ventilation.  The question of conservative management for occult 
pneumothorax was also briefly mentioned in a larger review on blunt chest trauma in 
2015.19 The review’s authors added one RCT and two retrospective cohort studies 
that showed no difference in terms of length of stay and mortality between 
observation and ICC insertion for occult pneumothorax.  When exposed to 
mechanical ventilation the authors felt the risk of tension pneumothorax was 
acceptable, without specifically stating what that risk was. 
How to best manage an occult pneumothorax in mechanically ventilated patients is 
important, as a significant proportion of trauma patients will receive mechanical 
ventilation either within intensive care or the emergency department or for the 
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provision of general anaesthesia. This review will identify the best available 
evidence to evaluate the effectiveness and safety of conservative management 
compared to ICC insertion for occult pneumothorax in mechanically ventilated 
patients.  The review of available evidence will specifically investigate progression 
of pneumothorax, incidence of ICC insertion for any reason, incidence of tension 
pneumothorax and incidence of pneumonia/empyema. 
 
Keywords 
Conservative Management; Mechanical Ventilation; Observation; Occult 




The review will consider studies that include stable patients of any age who are 
diagnosed with a traumatic occult pneumothorax on thoracoabdominal CT scan and 
receiving mechanical ventilation.  Mechanical ventilation can occur in the 
emergency department, intensive care unit or as part of the provision of general 
anaesthesia. The review will consider occult pneumothoraces caused by either blunt 




This review will consider studies that evaluate conservative 
management/observation for occult pneumothorax.  Conservative management 
includes clinical observation, serial examinations and/or serial chest x-rays. 
 
Comparator(s) 
This review will consider studies that compare the intervention to ICC insertion for 
occult pneumothorax.  The ICC can be inserted via any method, including Seldinger 
technique or blunt dissection.20 
 
Outcomes 
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The primary outcomes of interest are: progression of pneumothorax (seen on chest 
x-ray), ICC insertion for any reason, incidence of tension pneumothorax (diagnosed 
clinically) and incidence of pneumonia/empyema 
The secondary outcomes of interest are: mortality, ICC insertion (tension 
pneumothorax), ICC insertion (progression to simple pneumothorax), ICC insertion 
(non-pneumothorax reasons), length of stay in hospital and intensive care (in days), 
duration of mechanical ventilation (in days), duration of ICC dwelling (in days), 
haemodynamic instability (measured as need for vasopressor support), pain 
(measured by a validated pain scoring tools for sedated ICU patients i.e. Behavioural 
pain scale (BPS) and Critical-Care Pain Observation Tool (CPOT))21-23 and 
analgesia requirements (measured in parenteral morphine equivalents per 24 hours 
as per ANZCA opioid conversion)24 
This review will also consider adverse events/complications of ICC insertion 
(measured as composite and breakdown; including malpositioning, infection, organ 
injury and vascular injury). 
 
Types of Studies 
This review will consider both experimental and quasi-experimental study designs 
including randomized controlled trials and non-randomized controlled trials. In 
addition, observational studies including prospective and retrospective cohort studies 
will be considered for inclusion.  
 
Methods 
The proposed systematic review will be conducted in accordance with the Joanna 
Briggs Institute methodology for systematic reviews of effectiveness evidence.25 
PROSPERO Registration number: awaiting registration 
 
Search Strategy 
The search strategy aims to locate both published and unpublished studies. An initial 
limited search of PubMed was undertaken to identify articles on the topic. The text 
words contained in the titles and abstracts of relevant articles, and the index terms 
used to describe the articles were used to develop a full search strategy for PubMed 
(see Appendix 1). The search strategy, including all identified keywords and index 
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terms, will be adapted for the following databases: PubMed, EMBASE, CINAHL, 
Web of Science and Cochrane Central Register of Controlled Trials. Sources of 
unpublished studies will include: The International clinical trials registry (ICTR), 
Australian and New Zealand clinical trials registry (ANZCTR) and 
Clinicaltrials.gov. The reference list of all studies selected for inclusion will be 
screened for additional studies.  
 
Study Selection 
Following the search, all identified records will be collated and uploaded 
into Endnote X8.2 (Clarivate Analytics, PA, USA) and duplicates removed. Titles 
and abstracts will then be screened by one reviewer (JS) for assessment against the 
inclusion criteria for the review. Potentially relevant studies will be retrieved in full 
and their citation details imported into  the JBI System for the Unified Management, 
Assessment and Review of Information (JBI SUMARI 2017) (Joanna Briggs 
Institute, Adelaide, Australia).26 The full text of selected citations will be assessed in 
detail against the inclusion criteria by one reviewer (JS). Reasons for exclusion of 
full text studies that do not meet the inclusion criteria will be recorded and reported 
in the systematic review. Any uncertainties that arise at each stage of the study 
selection process will be resolved through discussion with a second reviewer (PS, 
EA). The results of the search and study inclusion process will be reported in full in 
the final systematic review and presented in a Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA) flow diagram.27  
 
Assessment of Methodological Quality 
Eligible studies will be critically appraised by two independent reviewers (JS, AV) 
at the study level for methodological quality in the review using standardized critical 
appraisal instruments from the Joanna Briggs Institute for experimental, quasi-
experimental studies and comparable cohort studies.25   Authors of papers will be 
contacted to request missing or additional data for clarification, where required. Any 
disagreements that arise will be resolved through discussion, or with a third reviewer 
(PS, EA). The results of critical appraisal of the included studies will be reported in 
narrative form and in a table. 
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Given the limited quantity of expected literature in this field, studies will not be 
excluded based on low methodological quality and high risk of bias, rather, study 




Data will be extracted from studies included in the review using a modified 
standardized data extraction tool25 (see appendix II). The data extracted will include 
specific details about the populations, study methods, interventions, and outcomes of 
significance to the review objective.  Outcomes include: progression of 
pneumothorax, ICC insertion for any reason, incidence of tension pneumothorax, 
incidence of pneumonia/empyema, ICC insertion (tension pneumothorax), ICC 
insertion (progression to simple pneumothorax), ICC insertion (non-pneumothorax 
reasons), length of stay in Hospital and Intensive Care, duration of mechanical 
ventilation, duration of ICC dwelling, haemodynamic instability, ICC complications 
(including malpositioning, infection, organ injury and vascular injury), pain and 
analgesia requirements. 
Insertion technique for ICC insertion in both groups will be extracted where 
possible. 
Any uncertainties that arise at each stage of the data extraction process will be 
resolved through discussion with a second reviewer (PS, EA). Authors of papers will 
be contacted to request missing or additional data, where required.  
 
Data Synthesis 
Studies will, where possible, be pooled in statistical meta-analysis using JBI 
SUMARI. Effect sizes will be expressed as either odds ratios (for dichotomous data) 
and weighted (or standardized) final post-intervention mean differences (for 
continuous data) and their 95% confidence intervals will be calculated for 
analysis.  Heterogeneity will be assessed statistically using the standard chi-squared 
and I squared tests. The choice of model (random or fixed effects) and method for 
meta-analysis will be based on the guidance by Tufunaru et al.29  Experimental and 
observational data will be synthesised in separate meta-analyses for each outcome.  
Impact of study quality and differences in sample size, age of patients (adult vs 
child) and insertion technique (blunt dissection vs Seldinger) will be explored using 
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sensitivity analysis.  Where statistical pooling is not possible the findings will be 
presented in narrative form including tables and figures to aid in data presentation 
where appropriate. A funnel plot will be generated to assess publication bias if there 
are 10 or more studies included in a meta-analysis. Statistical tests for funnel plot 
asymmetry (Egger test, Begg test, Harbord test) will be performed where 
appropriate. 
 
Assessing Certainty in the Findings 
The Grading of Recommendations, Assessment, Development and Evaluation 
(GRADE) approach for grading the certainty of evidence will be followed30 and a 
Summary of Findings (SoF) will be created using GRADEPro GDT 2015 
(McMaster University, ON, Canada). The SoF will present the following 
information where appropriate: absolute risks for the treatment and control, 
estimates of relative risk, and a ranking of the quality of the evidence based on the 
risk of bias, directness, heterogeneity, precision and risk of publication bias of the 
review results.  
The outcomes reported in the SoF will be: Progression of pneumothorax, Incidence 
of ICC insertion for any reason, incidence of tension pneumothorax, incidence of 
pneumonia/empyema, incidence of ICC complications, ICU and Hospital length of 
stay, duration of mechanical ventilation and mortality.  
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Appendix 2: Search strategy 
PubMed search strategy 
 
(Pneumothorax[mh] OR pneumothora*[tw] OR collapsed lung[tw]) AND (Artificial 
respiration[mh] OR Intermittent Positive-Pressure Ventilation[mh] OR Positive 
Pressure Respiration[mh] OR mechanical ventilation[tw] OR mechanical vent*[tw] 
OR IPPV[tw] OR intermittent positive-pressure ventilation[tw] OR intermittent 
positive pressure vent*[tw] OR biphasic intermittent positive airway pressure[tw] 
OR PPV[tw] OR positive pressure vent*[tw]) AND (Conservative treatment[mh] 
OR conservative[tw] OR conservative manage*[tw] OR conservative treatment[tw] 
OR observation[tw] OR observ*[tw] OR expectant manage*[tw] OR managed 
expectantly[tw] OR watchful waiting[mh] OR Chest tubes[mh] OR chest tube[tw] 
OR intercostal catheter[tw] OR intercostal tube[tw] OR intercostal drain[tw] OR 
chest drain[tw] OR ICC[tw] OR chest catheter[tw] OR thoracocentesis[mh] OR 
thoracocentesis[tw] OR thoracentesis[tw] OR pleurocentesis[mh] OR 
pleurocentesis[tw] OR chest intubation[tw] OR tube thoracostomy[tw] OR pleural 
drainage[tw] OR thoracostomy[mh]) 
 
595 results  –  17th June 2019 
  
Pneumothorax Mechanical ventilation Conservative management  
Or  







OR Positive Pressure 
Respiration[mh] OR 
mechanical ventilation[tw] 
OR mechanical vent*[tw] 
OR IPPV[tw] OR 
intermittent positive-
pressure ventilation[tw] 
OR intermittent positive 
pressure vent*[tw] OR 
biphasic intermittent 
positive airway 
pressure[tw] OR PPV[tw] 
OR positive pressure 
vent*[tw] 
Conservative treatment[mh] 





observ*[tw] OR expectant 
manage*[tw] OR managed 
expectantly[tw] OR 
watchful waiting[mh] OR 
Chest tubes[mh] OR chest 
tube[tw] OR intercostal 
catheter[tw] OR intercostal 
tube[tw] OR intercostal 
drain[tw] OR chest 
drain[tw] OR ICC[tw] OR 





pleurocentesis[tw] OR chest 
intubation[tw] OR tube 
thoracostomy[tw] OR 
pleural drainage[tw] OR 
thoracostomy[mh] 
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Embase search strategy  
 
(‘Pneumothorax’/exp OR ‘pneumothora*’:ti,ab OR ‘collapsed lung’:ti,ab) AND 
(‘artificial ventilation’/exp OR  'intermittent positive pressure ventilation'/exp OR  
‘artificial respiration’:ti,ab OR ‘Intermittent Positive-Pressure Ventilation’:ti,ab OR 
‘Positive Pressure Respiration’:ti,ab OR ‘mechanical ventilation’:ti,ab  OR 
‘mechanical vent*’:ti,ab OR ‘IPPV’:ti,ab OR ‘intermittent positive pressure 
vent*’:ti,ab OR ‘biphasic intermittent positive airway pressure’:ti,ab OR ‘PPV’:ti,ab 
OR ‘positive pressure vent*’:ti,ab) AND ('conservative treatment'/exp OR 
'intercostal catheter'/exp OR  ‘Conservative treatment’:ti,ab  OR ‘conservative’:ti,ab  
OR ‘conservative manage*’:ti,ab OR ‘Observation’:ti,ab  OR ‘observ*’:ti,ab  OR 
‘Expectant manage*’:ti,ab  OR ‘managed expectantly’:ti,ab  OR ‘watchful 
waiting’:ti,ab OR ‘chest tube’/exp OR ‘chest tube‘:ti,ab OR ‘intercostal 
catheter’:ti,ab  OR ‘intercostal tube’:ti,ab  OR ‘intercostal drain’:ti,ab  OR ‘chest 
drain’:ti,ab  OR ‘ICC’:ti,ab  OR ‘chest catheter’:ti,ab  OR ‘thoracocentesis’/exp OR 
‘thoracocentesis’:ti,ab OR ‘thoracentesis’:ti,ab OR ‘pleurocentesis’:ti,ab OR ‘chest 
intubation’:ti,ab  OR ‘tube thoracostomy’:ti,ab  OR ‘pleural drainage’:ti,ab  OR 
‘thoracostomy’/exp) 
1694 results – 17th June 2019  
Pneumothorax Mechanical ventilation Conservative management  
Or  





OR  'intermittent positive 
pressure ventilation'/exp 




OR ‘Positive Pressure 
Respiration’:ti,ab OR 
‘mechanical 
ventilation’:ti,ab  OR 
‘mechanical vent*’:ti,ab 
OR ‘IPPV’:ti,ab OR 
‘intermittent positive 




‘PPV’:ti,ab OR ‘positive 
pressure vent*’:ti,ab 
'conservative treatment'/exp 
OR 'intercostal catheter'/exp 
OR  ‘Conservative 
treatment’:ti,ab  OR 
‘conservative’:ti,ab  OR 
‘conservative 
manage*’:ti,ab OR 
‘Observation’:ti,ab  OR 
‘observ*’:ti,ab  OR 
‘Expectant manage*’:ti,ab  
OR ‘managed 
expectantly’:ti,ab  OR 
‘watchful waiting’:ti,ab OR 
‘chest tube’/exp OR ‘chest 
tube‘:ti,ab OR ‘intercostal 
catheter’:ti,ab  OR 
‘intercostal tube’:ti,ab  OR 
‘intercostal drain’:ti,ab  OR 
‘chest drain’:ti,ab  OR 
‘ICC’:ti,ab  OR ‘chest 





‘chest intubation’:ti,ab  OR 
‘tube thoracostomy’:ti,ab  
OR ‘pleural drainage’:ti,ab  
OR ‘thoracostomy’/exp 
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CINAHL search strategy 
 
Pneumothorax Mechanical ventilation Conservative management  
Or  
Intercostal catheter  
MH “pneumothorax”+ OR 
TI “pneumothorax*” OR 
AB “pneumothorax*” OR 
TI “collapsed lung” OR AB 
“collapsed lung” 
MH “respiration, 
artificial”+ OR MH 
“positive pressure 
ventilation”+ OR TI 
“artificial respiration” OR 
AB “artificial respiration” 
OR TI “artificial 
ventilation” OR AB 
“artificial ventilation” OR 
TI “intermittent positive 
pressure ventilation” OR 
AB “intermittent positive 
pressure ventilation” OR 
TI “intermittent positive 
pressure vent*” OR AB 
“intermittent positive 
pressure vent*”  OR TI 
“positive pressure 
respiration” OR AB 
“positive pressure 
respiration” OR TI 
“mechanical ventilation” 
OR AB “mechanical 
ventilation” OR TI 
“mechanical vent*” OR 
AB “mechanical vent*” 
OR TI “IPPV” OR AB 
“IPPV” OR TI “PPV” OR 
AB “PPV” OR TI “positive 
pressure vent*” OR AB 
“positive pressure vent*” 
OR TI “biphasic 
intermittent positive airway 
pressure” or AB “biphasic 
intermittent positive airway 
pressure”  
MH “Thoracostomy”+ OR 
MH “chest tubes”+ OR  TI 
“chest tube” OR AB “chest 
tube” OR TI “chest drain” 
OR AB “chest drain” OR TI 
“intercostal catheter” OR 
AB “intercostal catheter” 
OR TI “intercostal drain” 
OR AB “intercostal drain” 
OR TI “intercostal tube” OR 
AB “ intercostal tube” OR 
TI “chest catheter” OR AB 
“chest catheter” OR TI 
“ICC” OR AB “ICC” OR TI 
“thoracocentesis” OR AB 
“thoracocentesis” OR TI 
“thoracentesis” OR AB 
“thoracentesis” OR TI 
“pleurocentesis” OR AB 
“pleurocentesis” OR TI 
“chest intubation” OR AB 
“chest intubation” OR TI 
“tube thoracostomy” OR 
AB “tube thoracostomy” 
OR TI “pleural drainage” 
OR AB “pleural drainage” 
OR TI “thoracostomy” OR 
AB “thoracostomy” OR TI 
“conservative treatment” 
OR AB “conservative 
treatment” OR TI 
“conservative” OR AB 
“conservative” OR TI 
“conservative manage*” OR 
AB “conservative mange*” 
OR TI “observation” OR 
AB “observation” OR TI 
“observ*” OR AB 
“observ*” OR TI “expectant 
manage*” OR AB 
“expectant manage*” OR TI 
“manage expectantly” OR 
AB “manage expectantly” 
OR TI “watchful waiting” 
OR AB “watchful waiting”  
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(MH “pneumothorax”+ OR TI “pneumothorax*” OR AB “pneumothorax*” OR TI 
“collapsed lung” OR AB “collapsed lung”) AND (MH “respiration, artificial”+ OR 
MH “positive pressure ventilation”+ OR TI “artificial respiration” OR AB “artificial 
respiration” OR TI “artificial ventilation” OR AB “artificial ventilation” OR TI 
“intermittent positive pressure ventilation” OR AB “intermittent positive pressure 
ventilation” OR TI “intermittent positive pressure vent*” OR AB “intermittent 
positive pressure vent*”  OR TI “positive pressure respiration” OR AB “positive 
pressure respiration” OR TI “mechanical ventilation” OR AB “mechanical 
ventilation” OR TI “mechanical vent*” OR AB “mechanical vent*” OR TI “IPPV” 
OR AB “IPPV” OR TI “PPV” OR AB “PPV” OR TI “positive pressure vent*” OR 
AB “positive pressure vent*” OR TI “biphasic intermittent positive airway pressure” 
or AB “biphasic intermittent positive airway pressure”) AND (MH 
“Thoracostomy”+ OR MH “chest tubes”+ OR  TI “chest tube” OR AB “chest tube” 
OR TI “chest drain” OR AB “chest drain” OR TI “intercostal catheter” OR AB 
“intercostal catheter” OR TI “intercostal drain” OR AB “intercostal drain” OR TI 
“intercostal tube” OR AB “ intercostal tube” OR TI “chest catheter” OR AB “chest 
catheter” OR TI “ICC” OR AB “ICC” OR TI “thoracocentesis” OR AB 
“thoracocentesis” OR TI “thoracentesis” OR AB “thoracentesis” OR TI 
“pleurocentesis” OR AB “pleurocentesis” OR TI “chest intubation” OR AB “chest 
intubation” OR TI “tube thoracostomy” OR AB “tube thoracostomy” OR TI “pleural 
drainage” OR AB “pleural drainage” OR TI “thoracostomy” OR AB “thoracostomy” 
OR TI “conservative treatment” OR AB “conservative treatment” OR TI 
“conservative” OR AB “conservative” OR TI “conservative manage*” OR AB 
“conservative mange*” OR TI “observation” OR AB “observation” OR TI 
“observ*” OR AB “observ*” OR TI “expectant manage*” OR AB “expectant 
manage*” OR TI “manage expectantly” OR AB “manage expectantly” OR TI 
“watchful waiting” OR AB “watchful waiting”) 
 
97 results – 17th June 2019 
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Web of Science search strategy  
 
TS=(pneumothora* OR “collapsed lung”) AND TS=(“mechanical ventilation” OR 
“mechanical vent*” OR “IPPV” OR “PPV” OR “intermittent positive-pressure 
vent*” OR “intermittent positive pressure vent*” OR “biphasic intermittent positive 
airway pressure” OR “positive pressure vent*” OR “artificial respiration” OR 
“positive pressure respiration”) AND TS=(“conservative treatment” OR 
“conservative” OR “conservative mange*” OR “observation” OR “observe*” OR 
“expectant manage*” OR “manage expectantly” OR “watchful waiting” OR “chest 
tube” OR “chest drain” OR “chest catheter” OR “chest intubation” OR “intercostal 
catheter” OR “intercostal drain” OR “intercostal tube” OR “ICC” OR 
“thoracocentesis” OR “thoracentesis” OR “pleurocentesis” OR “tube thoracostomy” 
OR “pleural drainage” OR “thoracostomy”) 
 
566 results – 17th June 2019  
Pneumothorax Mechanical ventilation Conservative management  
Or  





“mechanical vent*” OR 
“IPPV” OR “PPV” OR 
“intermittent positive-
pressure vent*” OR 
“intermittent positive 
pressure vent*” OR 
“biphasic intermittent 
positive airway pressure” 
OR “positive pressure 
vent*” OR “artificial 





“conservative mange*” OR 
“observation” OR 
“observe*” OR “expectant 
manage*” OR “manage 
expectantly” OR “watchful 
waiting” OR “chest tube” 
OR “chest drain” OR “chest 
catheter” OR “chest 
intubation” OR “intercostal 
catheter” OR “intercostal 
drain” OR “intercostal 
tube” OR “ICC” OR 
“thoracocentesis” OR 
“thoracentesis” OR 
“pleurocentesis” OR “tube 
thoracostomy” OR “pleural 
drainage” OR 
“thoracostomy”) 
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Cochrane Central Register of Controlled Trials search strategy  
 
([mh pneumothorax] OR ‘pneumothora*’:ti,ab OR ‘collapsed lung’:ti,ab) AND ([mh 
“respiration, artificial”] OR [mh “ventilators, mechanical”] OR [mh “positive-
pressure respiration”] OR [mh “intermittent positive-pressure ventilation”] OR [mh 
“intermittent positive-pressure breathing”] OR ‘artificial respiration’:ti,ab OR 
‘Intermittent Positive-Pressure Ventilation’:ti,ab OR ‘Positive Pressure 
Respiration’:ti,ab OR ‘mechanical ventilation’:ti,ab  OR ‘mechanical vent*’:ti,ab 
OR ‘IPPV’:ti,ab OR ‘intermittent positive pressure vent*’:ti,ab OR ‘biphasic 
intermittent positive airway pressure’:ti,ab OR ‘PPV’:ti,ab OR ‘positive pressure 
vent*’:ti,ab) AND ([mh “chest tubes”] OR [mh “thoracentesis”] OR [mh 
“thoracostomy”] OR [mh “conservative treatment”] OR [mh “observation”] OR [mh 
“watchful waiting”] OR  ‘Conservative treatment’:ti,ab  OR ‘conservative’:ti,ab  OR 
‘conservative manage*’:ti,ab OR ‘Observation’:ti,ab  OR ‘observ*’:ti,ab  OR 
‘Expectant manage*’:ti,ab  OR ‘managed expectantly’:ti,ab  OR ‘watchful 
waiting’:ti,ab OR ‘chest tube‘:ti,ab OR intercostal catheter’:ti,ab  OR ‘intercostal 
tube’:ti,ab  OR ‘intercostal drain’:ti,ab  OR ‘chest drain’:ti,ab  OR ‘ICC’:ti,ab  OR 
Pneumothorax Mechanical ventilation Conservative management  
Or  
Intercostal catheter  




artificial”] OR [mh 
“ventilators, mechanical”] 
OR [mh “positive-pressure 
respiration”] OR [mh 
“intermittent positive-
pressure ventilation”] OR 
[mh “intermittent positive-




OR ‘Positive Pressure 
Respiration’:ti,ab OR 
‘mechanical 
ventilation’:ti,ab  OR 
‘mechanical vent*’:ti,ab 
OR ‘IPPV’:ti,ab OR 
‘intermittent positive 




‘PPV’:ti,ab OR ‘positive 
pressure vent*’:ti,ab 
[mh “chest tubes”] OR [mh 
“thoracentesis”] OR [mh 
“thoracostomy”] OR [mh 
“conservative treatment”] 
OR [mh “observation”] OR 
[mh “watchful waiting”] OR  
‘Conservative 
treatment’:ti,ab  OR 
‘conservative’:ti,ab  OR 
‘conservative 
manage*’:ti,ab OR 
‘Observation’:ti,ab  OR 
‘observ*’:ti,ab  OR 
‘Expectant manage*’:ti,ab  
OR ‘managed 
expectantly’:ti,ab  OR 
‘watchful waiting’:ti,ab OR 
‘chest tube‘:ti,ab OR 
intercostal catheter’:ti,ab  
OR ‘intercostal tube’:ti,ab  
OR ‘intercostal drain’:ti,ab  
OR ‘chest drain’:ti,ab  OR 





‘chest intubation’:ti,ab  OR 
‘tube thoracostomy’:ti,ab  
OR ‘pleural drainage’:ti,ab 
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‘chest catheter’:ti,ab OR ‘thoracocentesis’:ti,ab OR ‘thoracentesis’:ti,ab OR 
‘pleurocentesis’:ti,ab OR ‘chest intubation’:ti,ab  OR ‘tube thoracostomy’:ti,ab  OR 
‘pleural drainage’:ti,ab) 
 
103 results– 17th June 2019 
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International Clinical Trial Registry search strategy 
 (http://apps.who.int/trialsearch/AdvSearch.aspx) 
Advanced Search  
In Title: Pneumothorax OR pneumothoraces 
104 results – 17th June 2019 
 
Australian and New Zealand Clinical Trial Registry Search Strategy  
 (https://www.anzctr.org.au/TrialSearch.aspx) 
Advanced Search: 
pneumothorax OR pneumothoraces 
87 results – 17th June 2019 
 
Clinicaltrials.gov search strategy  
(https://clinicaltrials.gov/ct2/search/advanced?cond=&term=&cntry=&state=&city=
&dist=) 
Advanced Search  
In Condition: (pneumothorax OR pneumothoraces) 
110 results – 17th June 2019 
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Appendix 3: Excluded studies and reasons for their exclusion  
 
Article/trial Barrios C, Tran T, Malinoski D, Lekawa M, Dolich M, Lush S, et 
al. Successful management of occult pneumothorax without tube 
thoracostomy despite positive pressure ventilation. The American 
Surgeon. 2008;74(10):958–61. 
Reason for exclusion No comparison group; study was set up to examine patients who 
were managed without an ICC. "Medical records were then 
reviewed to identify patients in which management without 
immediate tube thoracostomy was attempted." 
 
 
Article/trial University of Calgary, CHU de Quebec-Universite Laval, 
Sunnybrook Health Sciences Centre, Canadian Intensive Care 
Foundation, London Health Sciences Centre. Management of 
Occult Pneumothoraces in Mechanically Ventilated Patients. 
2006. 
Reason for exclusion Trial currently underway, in recruitment stages. 
 
 
Article/trial Moore FO, Goslar PW, Coimbra R, Velmahos G, Brown CVR, 
Coopwood TB, et al. Blunt traumatic occult pneumothorax: Is 
observation safe? - results of a prospective, AAST multicenter 
study. Journal of Trauma - Injury, Infection and Critical Care. 
2011;70(5):1019–25. 
Reason for exclusion No comparison group; prospective study undertaken to identify 
patients with occult pneumothorax. Only followed patients who 
underwent observation. "Patients were classified according to 
whether they received immediate tube thoracostomy or 
underwent observation.  The observed patients were followed 
until hospital discharge."  Study then examined differences 
between those who were successfully observed and those who 
were not. 





Article/trial Lamb ADG, Qadan M, Gray AJ. Detection of occult 
pneumothoraces in the significantly injured adult with blunt 
trauma. European Journal of Emergency Medicine. 
2007;14(2):65–7. 
Reason for exclusion No relevant data; study examined incidence of occult 
pneumothorax and impact of detection on subsequent 
management.  Did not examine outcome differences of 
management of occult pneumothorax.  Also, all patients with 
occult pneumothoraces receiving mechanical ventilation were 
treated with an ICC. 
 
 
Article/trial Kaiser M, Whealon M, Barrios C, Dobson S, Malinoski D, 
Dolich M, et al. The clinical significance of occult thoracic injury 
in blunt trauma patients. The American Surgeon. 
2010;76(10):1063–6. 
Reason for exclusion No relevant data; study examined incidence of occult thoracic 
injuries and outcomes between occult and overt thoracic injuries.  
Management of occult pneumothorax not included in study. 
 
Article/trial Kirkpatrick AW, vanWijngaarden Stephens M, Fabian T. 
Canadian Association of General Surgeons and American 
College of Surgeons Evidence Based Reviews in Surgery. 18 - 
Treatment of occult pneumothoraces from blunt trauma. 
Canadian Journal of Surgery. 2006;49(5):358–61. 
Reason for exclusion Commentary on previously published randomised controlled trial 
(Brasel et al.). 






Article/trial Wolfman NT, Gilpin JW, Bechtold RE, Meredith JW, Ditesheim 
JA. Occult pneumothorax in patients with abdominal trauma: CT 
studies. Journal of Computer Assisted Tomography. 
1993;17(1):56–9. 
Reason for exclusion No relevant data; study examined different management 
strategies for their subclasses of occult pneumothorax. Only 
minuscule group would be appropriate based on management 
strategy, however no data available on which patients were 
mechanically ventilated. 
Article/trial Johnson G. Traumatic pneumothorax: is a chest drain always 
necessary? Journal of Accident and Emergency Medicine. 
1996;13(3):173–4. 
Reason for exclusion No relevant data; retrospective study examining the management 
of traumatic pneumothorax, however no mention of occult 
pneumothorax.  "Small" and "minimal" used to describe some 
pneumothoraces in study, however no mention of how these were 
quantified or if all patients received CT scans. 
Article/trial Walker S, Barratt S, Thompson J, Maskell N.  Conservative 
Management in Traumatic Pneumothoraces: An Observational 
Study. Chest. 2018 153(4): 946-953 
Reason for exclusion No relevant data; data for occult pneumothoraces not separated 
out in article and author not contactable due to undeliverable 
email address. 
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Appendix 4: Critical appraisal explanatory tables  
Randomised controlled trials 
1. Was true randomization used for assignment of participants to treatment 
groups? 
Yes Clear explanation of how randomization was achieved and would 
lead to true randomization  
No Assignment was not random 
Unclear Words ‘random’ or ‘randomisation’ used, but vague or unclear 
explanation of how this was achieved 
 
2. Was allocation to treatment groups concealed? 
Yes Methods used to ensure allocator was unaware of which group 
patient would be allocated to AND allocator was unlikely to be 
aware of order of allocation 
No Allocator aware of group that patient would be assigned or could 
reasonably figure it out 
Unclear Unclear or insufficient information provided on allocation 
concealment 
 
3. Were treatment groups similar at baseline? 
Yes Groups similar at baseline in at least the following categories  
o Age  
o Sex  
o Severity of trauma (i.e. injury severity score -ISS) 
No Statistically significant difference in above baseline characteristics   
Unclear Baseline characteristics not stated or incomplete 
 
4. Were participants blind to treatment assignment? 
Yes  
No Due to exposure/intervention not possible to blind participants 
Unclear  
 
5. Were those delivering treatment blind to treatment assignment? 
Yes  
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6. Were outcomes assessors blind to treatment assignment? 
Yes Clear explanation of how assessors were blinded to treatment 
assignment  
No Assessors not blinded to treatment allocation 
Unclear No or unclear explanation of how assessors were blinded to 
treatment assignment 
 
7. Were treatment groups treated identically other that the intervention of 
interest?  
Yes Other than intervention of interest, was same standard of care 
provided to each group  
No Stated clear differences in treatment of groups 
Unclear Treatment other than intervention not clearly stated 
 
8. Was follow up completed and if not, were differences between groups in 
terms of their follow up adequately described and analysed? 
Yes Number of patients lost to follow up and reason in each group 
stated AND how loss to follow up altered results analysed  
No No explanation of loss of follow up or significance of this loss 
Unclear Unclear why loss to follow up occurred and unclear how this altered 
results 
 
9. Were participants analysed in the groups to which they were randomised? 
Yes patient analysed on intention to treat  
No Participants not analysed in groups they were allocated 
Unclear Unclear if patients were analysed in the group they were 
randomised to 
 
10. Were outcomes measured in the same way for treatment groups? 
Yes Clear definition of outcomes and clear description of how outcomes 
were to be measured, using validated tools were applicable 
No Inappropriate or non-validated tools used, or different methods used 
in each group 
Unclear Unclear how outcomes were measured  
 
11. Were outcomes measured in a reliable way? 
Yes  the measurement can be easily reproduced 
No Outcomes measured in a way that can’t easily be reproduced 
Unclear Unclear how outcomes were measured 
 
Page 111 of 146 
 
12. Was appropriate statistical analysis used? 
Yes Appropriate statistical methods used, which were adequately 
described and reported.  
No Inappropriate tests used or methods not described. 
Unclear Unclear explanation of method of statistical analysis 
 
13. Was the trial design appropriate, and any deviations from the standard RCT 
design (individual randomization, parallel groups) accounted for in the 
conduct and analysis of the trial? 
Yes Was the design appropriate for the question the trial was seeking to 
answer AND were any deviations from standard RCT design clearly 
described 
No Question clearly would have been answered better with another 
study design 





All studies will 
be included 




Comments (please include: areas that require further information, areas where there 
are methodological flaws, strengths and weaknesses of trial) 
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Cohort studies 
1. Were the two groups similar and recruited from the same population? 
Yes All patients were recruited from same population i.e. trauma 
patients 
No Patients in two groups recruited from different populations 
Unclear Unclear explanation of where patients recruited from  
 
2. Were the exposures measured similarly to assign people to both exposed and 
unexposed groups? 
Yes Can only be yes, as exposure is occurrence or non-occurrence of a 




3. Was the exposure measured in a valid and reliable way? 
Yes Can only be yes, as exposure is occurrence or non-occurrence of a 




4. Were confounding factors identified? 
Yes Clear description of confounding factors 
No No effort made to describe possible confounders 
Unclear Vague description of possible confounders 
 
5. Were strategies to deal with confounding factors stated? 
Yes Clear description of how confounders were dealt with  
No No description of how confounders were dealt with  
Unclear Vague description of strategies used 
 
6. Were the groups/participants free of the outcome at the start of the study (or 
at the moment of exposure)? 
Yes Participants free of intercostal catheter prior to diagnosis of occult 
pneumothorax 
No Some participants had intercostal catheter in prior to diagnosis of 
occult pneumothorax 
Unclear Unclear timing of intercostal catheter insertion and diagnosis of 
occult pneumothorax 
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7. Were the outcomes measured in a valid and reliable way? 
Yes The measurement can be easily reproduced AND clearly describes 
outcomes and measured in a standardised way using validated tools 
were appropriate 
No Outcomes measured in a way that cannot easily be reproduced, 
using inappropriate or non-standardised way  
Unclear Unclear how outcomes were measured 
 
8. Was the follow-up time reported and sufficient to be long enough for 
outcomes to occur? 
Yes Follow-up time was reported i.e. ‘to hospital discharge’  
No Follow-up time not reported or a period of time shorter than ‘to 
hospital discharge’ 
Unclear Vague explanation of follow up time 
 
9. Was follow-up complete, and if not, were reasons to loss to follow-up 
described and explored? 
Yes Clear description of how many lost to follow-up and reasons for 
this 
No No description of why lost to follow-up  
Unclear Partial description of either how many or why lost to follow-up  
 
10. Were strategies to address incomplete follow-up utilised? 
Yes Clearly described how incomplete follow-up may affect results  
No No explanation of how incomplete follow-up may affect results 
Unclear Vague explanation of how incomplete follow-up affected results 
 
11. Was appropriate statistical analysis used? 
Yes Appropriate statistical methods used, which were adequately 
described and reported.  
No Inappropriate tests used or methods not described. 










Comments (please include: areas that require further information, areas where there 
are methodological flaws, strengths and weaknesses of trial) 
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Appendix 5: Correspondence 
 
Below is the standardised email sent out to corresponding authors of studies 
published within the last 10 years. 
 
Dear …  
 
I am writing to you in regard to your publication… 
 
I am a Master of Clinical Sciences candidate at the University of Adelaide, and an 
intensive care registrar in Melbourne, Australia. 
As part of my degree I am conducting a systematic review examining the safety and 
effectiveness of conservative management of occult pneumothorax in mechanically 
ventilated patients. Your article may contain data that is relevant to this. 
 




I was hoping it would be possible for you to forward data from the subgroup of 
ventilated patients with occult pneumothoraces, that could be included in a meta-
analysis.  
The data that is of interested includes: 
1. Incidence of pneumothorax progression (and how this was measured)  
2. Incidence of tension pneumothorax  
3. Incidence of pneumonia/ empyema  
4. Incidence of ICC insertion (including reason for insertion) 
5. Mortality  
6. ICC complications (including type) 
7. Haemodynamic instability  
8. ICU and Hospital length of stay (in days) 
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9. ICC dwelling time (in days) 
10. Mechanical ventilation duration (in days) 
11. Pain scores (using validated tool i.e. Behavioural pain scale (BPS) and 
Critical-Care Pain Observation Tool (CPOT)) 
12. analgesia requirement (dose in morphine equivalent per 24 hours) 
 
If you have any description for insertion technique of ICC and type of CT scanner 
(and thickness of slices) used that would also be useful for my research. 
 
Data presented as mean and SD or median and IQR would be of most value, 
although if it’s easier to send raw data this would also be appreciated. 
 
To help better understand your study I was also hoping you would be able to clarify 
some details for me. 
1.   
 
Many thanks in advance  
 
Dr Jeremy Smith 
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Included studies  
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Lee et al. 200916 
 
No reply after multiple attempts to contact author. 
 




Multiple attempts were made to contact Dr Moore for further data with no response. 
 



















Wilson et al. 2009184 
 




Walker et al. 2018178 
 
 
No other contact details available.  
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Appendix 6: Data extraction tool   
Data extraction tool for experimental/observational studies 
Modified from JBI data extraction tool143  
 
Reviewer ________________________ Date__________________________ 
Primary Author ___________________ Year__________________________ 
Journal __________________________ Record number _________________ 
Study Methods 
RCT      Quasi-RCT  






Sample Size  
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Study results  
Dichotomous data 
Outcome  Conservative Management ICC 
Progression of Pneumothorax 
 
  






ICC insertion (any reason) 
 
  
ICC insertion (tension 
pneumothorax) 
  
















ICC complication  
(infection) 
  
ICC complication  
(organ injury) 
  




(Seldinger / blunt dissection) 
  
Continuous Data 
Outcome  Conservative Management ICC 
ICU length of stay    




Duration of ICC dwelling   
Pain   
Analgesia Requirements   
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Appendix 7: Sensitivity analysis 
7.1 Primary outcomes  
 
7.1.1 Progression of pneumothorax 
 
Figure 7.1: Randomised controlled trial progression of pneumothorax M-H forest plot 
(refer to Figure 3.2) 
 
 
Figure 7.2: Randomised controlled trial progression of pneumothorax Peto odds ratio forest 
plot (refer to Figure 3.2) 
 
 
Figure 7.3: Randomised controlled trial progression of pneumothorax without Enderson M-
H forest plot (refer to Section 3.4.1.1) 
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Figure 7.4: Cohort study progression of pneumothorax M-H forest plot (refer to Figure 3.3) 
 
 




7.1.2 Intercostal catheter insertion (any reason) 
 
Figure 7.6: Randomised controlled trial intercostal catheter insertion (any reason) M-H 
forest plot (refer to Figure 3.4) 
 
 
Figure 7.7: Randomised controlled trial intercostal catheter insertion (any reason) Peto 
odds ratio forest plot (refer to Figure 3.4) 
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Figure 7.8: Cohort study intercostal catheter insertion (any reason) M-H forest plot (refer 
to Figure 3.5) 
 
 
Figure 7.9: Cohort study intercostal catheter insertion (any reason) Peto odds ratio forest 
plot (refer to Figure 3.5) 
 
7.1.3 Incidence of pneumonia/empyema 
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Figure 7.11: Cohort study incidence of pneumonia/empyema Peto odds ratio forest plot 
(refer to Figure 3.6) 
 
7.2 Secondary outcomes  
7.2.1 Mortality  
 
Figure 7.12: Cohort study mortality M-H forest plot (refer to Figure 3.7) 
 
 
Figure 7.13: Cohort study mortality Peto odds ratio forest plot (refer to Figure 3.7) 
 
7.2.2 Intercostal catheter insertion (progression to simple pneumothorax) 
 
Figure 7.14: Randomised controlled trial intercostal catheter insertion (progression to 
simple pneumothorax) M-H forest plot (refer to Figure 3.8) 
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Figure 7.15: Randomised controlled trial intercostal catheter insertion (progression to 
simple pneumothorax) Peto odds ratio forest plot (refer to Figure 3.8) 
 
 
Figure 7.16: Randomised controlled trial intercostal catheter insertion (progression to 
simple pneumothorax) minus Enderson M-H forest plot (refer to Section 3.4.2.3) 
 
 
Figure 7.17: Cohort study intercostal catheter insertion (progression to simple 
pneumothorax) M-H forest plot (refer to Figure 3.9) 
 
 
Figure 7.18: Cohort study intercostal catheter insertion (progression to simple 
pneumothorax) Peto odds ratio forest plot (refer to Figure 3.9) 
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7.2.3 Intercostal catheter insertion (non-pneumothorax reasons) 
 
Figure 7.19: Cohort study intercostal catheter Insertion (non-pneumothorax reasons) M-H 
forest plot (refer to Figure 3.10) 
 
 
Figure 7.20: Cohort study intercostal catheter Insertion (non-pneumothorax reasons) Peto 
odds ratio forest plot (refer to Figure 3.10) 
 
7.2.4 Intercostal catheter complications (composite) 
 
Figure 7.21: Cohort study intercostal catheter complication (composite) M-H forest plot 
(refer to Figure 3.11) 
 
 
Figure 7.22: Cohort study intercostal catheter complication (composite) Peto odds ratio   
forest plot (refer to Figure 3.11)  
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